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Abstract Presentations 
The American College of Cardiology is pleased to announce that more than 6,150 abstracts of original contributions 
were submitted to the Program Committee of the 49th Annual Scientific Session. Space and time considerations this 
year allowed the selection of 2,200. Each paper was peer reviewed by a panel of graders; chosen abstracts are 
presented in either oral or poster format. The American College of Cardiology thanks the thousands of abstract 
participants and the hundreds of category graders and chairs for their efforts. 
William A. Zoghbi, MD, FACC 
Chair, 2000 Annual Scientific Session Program Committee 
Neal S. Kleiman, MD, FACC 
Co-Chair, 2000 Annual Scientific Session Program Committee 
Country 
UNITED STATES 
ARGENTINA 
AUSTRALIA 
AUSTRIA 
BELGIUM 
BRAZIL 
CANADA 
DENMARK 
FINLAND 
FRANCE 
GERMANY 
GREECE 
HONG KONG 
INDIA 
ISRAEL 
ITALY 
JAPAN 
Presentations 
1,257 57.14 KOREA 1 .05 
7 .32 NEW ZEALAND 3 .I4 
19 .86 NORTHERN IRELAND 2 .09 
5 .23 NORWAY 5 .23 
10 .45 PEOPLE’S REPUBLIC OF CHINA 3 .I4 
24 1.09 POLAND 6 .27 
76 3.45 PORTUGAL 4 .I8 
6 .27 SOUTH AFRICA 3 .I4 
8 .36 SOUTH KOREA 18 .82 
51 2.32 SPAIN 12 .55 
196 8.91 SWEDEN 14 .64 
33 1 so SWITZERLAND 27 1.23 
5 .23 TAIWAN, ROC 5 .23 
6 .27 THE NETHERLANDS 53 2.41 
19 .86 TURKEY 3 .I4 
79 3.59 UNITED KINGDOM 101 4.59 
135 6.14 YUGOSLAVIA 4 .I8 
ACC2000 TOTAL PRESENTATIONS: 2,200 
% 
of Total Country 
% 
Presentations of Total 
U.S.: 57.14% INTERNATIONAL: 42.86% 
The receipt deadline for submission of abstracts to be considered for presentation at the 
American College of Cardiology 50th Annual Scientific Session, March 18-21, 2001, 
in Orlando, Florida, is Friday, September 8, 2000. 

iv 
Scientific Sessions 
SESSION KEY 
Each education session has been assigned an icon and a number 
which correspond to the format in which the session is presented. 
400 Series = Special Sessions 
Sunday, March 12-Wednesday, March 15 pJ 
m mm 40-80 Series = Spotlight Sessions Sunday, March 12 m 
Three comprehensive programs in focused areas of cardiology are 
offered on Sunday: ACCIS 2000 (Interventional), ClinCard 2000 
(Clinical Cardiology), and Echo 2000 (Echocardiography). 
Programs feature live case demonstrations, expert faculty, and 
interactive case presentations. The registration fee includes lunch. 
ACC Member Ajiliates-in-Training may attend for $30, Registration 
Category 1 only. 
m $125 in Ad Vance and On-Site in Anaheim 
100 Series = Mini-Courses 
Sunday, March 12 
The purpose of these sessions is to provide an in-depth update, 
including research data, on topics of major clinical interest. The 
half-day courses generally appeal to practicing and academic 
clinical cardiovascular specialists. 
The Mini-Course fee is wa,ived for ACC Member Afiliates-in-Training, 
Registration Category 1. 
The purpose of these sessions is to address and discuss infor- 
mation presented by the panelists who are involved clinically or in 
research related to the topic. Audience participation is an integral 
part of these informal sessions. Each panelist will give a five- to 
seven-minute introduction with the remainder of the session 
devoted to questions and discussion. 
Objectives are that the participant will: 
1. Update his/her knowledge in the techniques, advancements, 
and new developments concerning the topic. 
2. Propose questions, areas or topics of interest, and “problem” 
cases or scenarios for discussion according to his/her needs. 
There is no charge to attend these sessions. 
m $56 in Advance/$65 after February 9, 2000 m 
Em 600 Series = Symposia 
m 
200 Series = Meet the Experts m Monday, March 13-Wednesday, March 15 pJ 
Monday, March 13-Wednesday, March 15 /pJ The purpose of these sessions is to present detailed discussions of 
cardiovascular topics by individuals who have directly contributed 
information to the subject. Symposia include sessions of both 
general clinical interest as well as sessions with focused interest 
for subspecialists in various aspects of scientific, clinical, and 
procedural cardiology. 
Among those highlighted are the Presidential Plenary Session, Clinical 
Decision Making, Young Investigators Awards Competition, Contm- 
versies in Cardiology, Annual Louis E Bishop Lecture, the Annual 
Convocation Ceremony, and the new Highlights Session on Wednesday. 
There is no charge to attend these session. 
m 500 Series = Evening Sessions Sunday, March 12 and Tuesday, March 14 pJj 
The purpose of these sessions is to provide a scholarly exchange 
of information in an informal setting between two recognized 
authorities and a small group of cardiologists. 
Objectives are that the participant will: 
1. Review the differential diagnosis, diagnostic logic and 
techniques, and current knowledge of disease and 
pathophysiology, where appropriate, in discussions. 
2. Identify and discuss his/her interests and needs. 
3. Participate actively. 
Attendees are encouraged to bring questions, and cases or 
scenarios for discussion. 
Attendance limited to 70. Open enrollment will be available to all 
professional registrants. 
m $50 in Advance/$65 after February 9, 2000 
m m 300 Series = Luncheon Panels Monday, March 13-Wednesday, March 15 @gJ 
The purpose of these sessions is to address current practice issues 
in cardiovascular medicine. A Chair and three to four panelists 
preside over an interactive discussion. Luncheon service continues 
until 12:45 p.m. when each panelist presents five- to seven-minute 
introductory remarks. The remaining 3040 minutes of the 
session are devoted to questions from the audience. Where appli- 
cable, a case presentation will be distributed to the audience for 
discussion at the end of the session. As audiovisual aids are not 
permitted, audience members are encouraged to bring questions 
and cases and participate in the discussion to fully benefit from 
the informal interchange. 
Objectives are that the participant will: 
1. Distinguish the major issues, techniques, and management 
options in cardiovascular practice. 
2. Discuss and ask questions about topics of interest. 
Attendee must artive at session no later than 12:30 p.m. or his/her ticket 
ma? be resold. 
m $35 in Advance and On-Site in Anaheim 
There is no charge to attend these sessions. 
m m 700 Series = Core Curricula Monday, March 13-Wednesday, March 15 pJ 
The purpose of these sessions is to provide practicing clinicians 
with comprehensive up-to-date information about developments 
in pathophysiology and therapy which are relevant to the care of 
patients, now and in the future. 
Objectives are that the participant will: 
1. Review and evaluate new directions and practices in cardiology. 
2. Integrate new concepts in basic mechanisms of disease into a 
clinical perspective. 
3. Examine results of recent clinical trials as they pertain to their 
immediate and future impact on clinical practice. 
There is no charge to attend these sessions. 
800-900 Series = 
Original Contributions-Oral 
Monday, March 13-Wednesday, March 15 
There is no charge to attend these sessions. 
1000-1200 Series = 
Original Contributions-Poster 
Sunday, March 12-Wednesday, March 15 
There is no charge to attend these sessions. 
ix 
by 8:30 a.m.-lo:00 a.m. 
-7 Late Breaking Clinical 
rrials II, Anaheim Convention 
Center, Arena 
m 8:30 a.m.-Noon 
m Controversies in 
Cardiology, Anaheim Convention 
Center, Ballroom C 
m 8:30 a.m.-lOzOO a.m. 
h Therapy With 
mplantable Cardioverter 
Iefibrillators KD), Anaheim 
Convention C&ter;~Ballroom A 
8:30 a.m.-lo:00 a.m. 
Atrial Fibrillation: 
?athophysiology, Anaheim 
Convention Center, Room 304C 
m 9~00 a.m.-lOzOO a.m. 
B New Antiarrhythmic 
Drugs, Anaheim Convention 
Center, Room 212A lm 
9:00 a.m.-II:00 a.m. 
Atrioventricular Nodal 
Physiology and SVT, Anaheim 
Convention Center, Hall A 
9:00 a.m.-II :OO a.m. 
Implantable 
Cardioverter-Defibrillators, 
Anaheim Convention Center, Ha// A 
9~00 a.m.-II:00 a.m. 
Lonq QT Syndrome, 
Anaheim Convekion center, Hall A 
m ~,3h;-ll~ll;pm.I. 
Techniques in Electrophysiology, 
Anaheim Convention Center, 
Room 209B a?@ 
-1 12:15 p.m.-l:45 p.m. 
B Update on Pacing, 
Hi/ton Anaheim, Laguna m 
m 12:15 p.m.-l:45 p.m. 
B Genetic Features of 
Cardiac Arrhythmia, Hi/ton 
Anaheim, Pales Vercies aa 
m 2:00 p.m.-3:OO p.m. 
B 31 st Annual Louis F. 
Bishop Lecture, Anaheim 
Convention Center, Ballroom A 
m IO:30 a.m.-Noon 
m Clinical Decision 
Making, Anaheim Convention 
Center, Room 2 J OA 
lo:30 a.m.-Noon 
Catheter-Based 
Ablation of Atrial flutter, 
Anaheim Convention Center, 
Room 304C 
Noon-2:00 p.m. 
Atrial Fibrillation/Atria1 
Flutter: Pathophysiology, Anaheim 
Convention Center, Hall A 
Noon-Z:00 p.m. 
Cardiac Pacing, 
Anaheim Convention Center, Hall A 
Noon-200 p.m. 
Ventricular Repolari- 
zation, Anaheim Convention 
Center, Ha// A 
4ntiarrhythmic Drugs, Anaheim 
Convention Center, Room 2 1 OA 
2~00 p.m.-3:30 p.m. 
Noninvasive Risk 
Detection, Anaheim Convention 
Center, Room 213A 
2:00 p.m.-3:30 p.m. 
Atrial Fibrillation: 
Basic Electrophysiology, Anaheim 
Convention Center, Room 304C 
300 p.m.-5:OO p.m. 
Basic Electro- 
Anaheim Convention 
Center, Hall A 
~00 p.m.-5:OO p.m. 
Mechanisms for 
Convention Center, Hall A 
300 p.m.-5:OO p.m. 
Atrial Fibrillation, 
Anaheim Convention Center, Hall A 
m 4~00 p.m.-500 p.m. 
B Ventricular 
Arrhythmias: Who to Treat?, 
Anaheim Convention Center, 
Room 2 1 IA #ID 
4:00 p.m.-I:00 p.m. 
Implantable 
Cardioverter Defibrillators and 
Antiarrhythmic Drugs, Anaheim 
Convention Center, Room 304C 
Convention Center, Room 304A 
m 5:30 p.m.-7:OO p.m. 
B Arrhythmias in 
Patients With Congenital Heart 
Disease, Anaheim Convention 
Center, Room 304C 
m 5~00 p.m.-&00 p.m. 
d 49th Annual 
Convocation, Disneyland Hotel, 
Terrazzo Room 
.,. 8 IO:30 a.m.-Noon 
m Late Breakinq Clinical -~~- 
Trials III Anaheim Convekion 
9130 a.m.-l&30 a.m. 
__,_.._  ... ..-. 
Center. Ballroom C 
1 ACC 2000 Meeting 
iighlights, Anaheim Convention 
Ienter, Arena 
8~30 a.m.-lOzOO a.m. 
Atrial Fibrillation: 
ogical Therapy, 
Anaheim Convention Center, 
,r\,-.m 7rlAf- 
m 10~30 a.m.-Noon I. 
B Atrial Fibrillation, 
Anaheim Convention Center. 
Room 2 I OA 
lo:30 a.m.-Noon 
Ventricular 
Arrhythmias/Mechanisms, 
\ “ “ , I ,  J”-rL 
9100 a.m.-1l:OO a.m. _ 
Anaheim Convention Center, 
Room 304C 
vention Center, Hall A 
9~00 a.m.-11 ~00 a.m. m 12:15 p.m.-l:45 p.m. . 
Conduction in Cardiac 
]L*II, Indications for 
Catheter Ablation, Hilton 
irrhythmias, Anaheim Convention 
Center, Hall A 
Anaheim, Capistraho 
9:00 a.m.-1l:OO a.m. 
Noninvasive Testing, 
4naheim Convention Center, Hall A 
m IO:30 a.m.-11:30 a.m. 
B Management of 
4rrhythmias During Pregnancy, 
4naheim Convention Center, 
Poom 209A aa 
V 
Noon-200 p.m. 
Intravascular 
Radiation, Anaheim Convention 
Center. Hall A 
m 1:30 p.m.-3SO p.m. 
~$%&vehtional Cardi 
otog~‘HigWiglited Abstract $Hig iglited 
Session: Fe&wed Topics. in 
Stentting, Anaheim Convention 
Cm&~ Lecfwe Hall A 7 4 
~~~~~~~~e~~~ ’ 
Center icaNrow3m C 
:--3SiO p.m.+30 p.m. 
‘w :MatchIng Lesions and 
bevicek Should Everyone Do 
Everything?, Anaheim Conventio(’ 
Center, Bdlraom A < ,’ 
~&pO p.m+5:30 p.m. 
:m Live iriterventionat 
Case Demonstrations 111: Mitral 
Val@oplasty and Atcohol 
Ablation of IiOCM (jaint Session 
With EchoZOUO), Anaheim 
Convenlion Center, Arena 
.B 4:OO p.m.-5:30 p.m. 
,m. lnterventional 
Cardiology Highlighted Abstract 
Session: Novel Therapies, (’ 
Anaheim Convention center, G  Center, 
Lecture Hall A7 
400 p.m.-6:00 p.m. 
Percutaneous 
Interventions: Coronary 
Noon-2:00 p.m. 
Coronary Stenting: 
tcomes, Anaheim 
Convention Center, Hall A 
Outcomes, Anaheim Convention 
Center, Hall A 
4~00 p.m.&00 p.m. 
Coronary Stenting: 
Basic Aspects, Anaheim 
Convention Center, Hall A 
heim Convention 
Stenting, Anaheim Convention 
Center, Ha// A 
4:OO p.m.-6:OO p.m. 
Restenosis: Basic 
Research I, Anaheim Convention 
Center, Hall A 
400 p.mA:OO p.m. 
IVIJS Insights Into 
Percutaneous Revascularization, 
Anaheim Convention Center, Hall A 
~$~~ 6$j$i~~i 
Cas6 demonstrations Ii, Anaheim 
Convention Center, Arena 
-$30 p.m.-3:16 p.m. 
I;r Comp4ications: 
Preveiltion, Recognition, and 
Management, Anaheim Conven- 
tion Center, Ballroom C 
m 1;30 p.m.-3A6 pm. 
B Problem Solving in 
lnteniehtional Cardiology, 
Anaheim Convention Center, 
Ballroom A 
m 5:30 p.m.-7:OO p.m. 
u Alternative Revascu- 
larization Strategies: PMR/DMR, 
Angiogenesis, Anaheim Conven- 
tion Center, Room 273A 
m 5:30 p.m.-7:OO p.m. 
w In-Stent Restenosis, 
Anaheim Convention Center, 
Lecture Hall A 7 
m 5:30 p.m.-7:OO p.m. 
m Radiation Devices, 
Anaheim Convention Center, 
Lecture Hall A2 
m 6:00 a.m.-g:00 a.m. 
m Presidential Plenary 
iession, Anaheim Convention 
Ienter, Arena 
B 9:00 a.m.-lOzOO a.m. 
B Cine Film Replace- 
nent, Anaheim Convention Center, 
?oom 2728 niz 
m 9:00 a.m.-IO:00 a.m. 
B Stent Selection, 
lnaheim Convention Center, 
ioom 208B IIa 
9:00 a.m.-1l:OO a.m. 
High Risk Subsets, 
Anaheim Convention Center, Hall A 
9~00 a.m.-II:00 a.m. 
9:00 a.m.-11:OO a.m. 
$neurysm, Anaheim Convention 
Center, Hall A 
9:00 a.m.-II:00 a.m. 
Restenosis: Basic 
iesearch II, Anuheim Convention 
Center, Hall A 
m 9~15 a.m.-l&30 a.m. 
B Late Breaking Clinical 
Trials I, Anaheim Convention 
Center, Ballroom C 
m 9:15 a.m.-ID:30 a.m. 
B ACC/AHA PTCA 
Guidelines, Anaheim Convention 
Center, Lecture Hall A 7 
E+ 9:15 a.m.-IO:30 a.m. 
B lntracoronary 
Radiation: Part I, Anaheim 
Convention Center, Lecture Hall A2 
9:15 a.m.-l&45 a.m. 
Covered Coronary 
Stent, Anaheim Convention center, 
Room 2 7 OA 
9:15 a.m.-l&30 a.m. 
New Approaches to 
Restenosis Prevention, Anaheim 
Convention Center, Room 207A 
m IO:00 a.m.-Noon 
m Live Interventional 
Case Demonstrations IV, Anaheim 
Convention Center, Arena 
M IO:30 a.m.-II :30 a.m. . . 
B Rotational Atherec- 
tomy, Anaheim Convention 
Center, Room 2 17A m 
IO:45 a.m.-12:15 p.m. 
Outcomes With 
m II:00 a.m.-12:15 p.m. . . 
w Current Status of 
Mitral Valvuloplasty, Anaheim 
Convention Center, Lecture Hall A 7 
II:00 a.m.-12:15 p.m. 
lntracoronary Radiation: 
naheim Convention 
Center, Lecture Hall A2 
II:00 a.m.-12:15 p.m. 
Long-Term Outcomes 
of Percutaneous Coronary 
Intervention, Anaheim Convention 
Center, Room 207A 
Noon-2:00 p.m. 
Closure Devices, 
Complications, Anaheim 
Convention Center, Hall A 
Noon-2:00 p.m. 
Coronary Stenting I, 
Anbheim Convention Center, Ho// A 
Noon-200 p.m. 
Restenosis: Basic and 
naheim Convention 
Center, Hall A 
Noon-2:00 p.m. 
Novel Catheter-Based 
Imaging Methods to Assess 
Plaque Stability I, Anaheim 
Convention Center, Hail A 
m 12:15 p.m.-l:45 p.m. . 
B GP Ilb-llla Inhibitors 
and Low Molecular Weiqht 
Heparin: When Should They 
Be Used?, Anaheim Marriott, 
Salon F m 
&uh.. 12:15 p.m.-l:45 p.m. 
m Renal Artery Stenosis: 
When and How to Treat, 
Hi/ton Anaheim, Laguna m 
m I:30 p.m.-3:30 p.m. 
w Interventional Case 
Demonstrations V, Anaheim 
Convention Center, Arena 
m 200 p.m.3:30 p.m. .I 
w Coronary Intervention 
Problem Solving, Anaheim 
Convention Center, Lecture Hall A7 
2~00 p.m.-3:30 p.m. 
Acute Coronary 
Syndromes, Anaheim Convention 
Center, Lecture Hall A2 
2:00 p.m.3:30 p.m. 
New Devices for 
Coronary Intervention, Anaheim 
Convention Center, Room 207A 
Coronary Stenting, Anaheim 
Convention Center, Room 2 7 OA 
vi 
m 2:OO p.m.-5:30 p.m. .  2 
m Joint Symposium: 
European Society of Cardiology, 
American College of Cardiology 
-Acute Coronary Syndromes... 
From Mechanisms to Thera- 
peutics, Anaheim Convention 
Center, Ballroom C 
Anaheim Convention Center, 
Room 208A I 
m 230 p.m.+%30 p.m. 
B Interventions: Adult 
Congenital Heart Disease, 
Anaheim Convention Center, 
Room 2085 I 
3~00 p.m.-5:OO p.m. 
Adjunctive Therapy, 
Antithrombotic, Cardiac 
Enzymes, Anaheim Convention 
Center, Ha// A 
3:OO p.m.S:OO p.m. 
IVUS Insights Into 
Coronary Stenting, Anaheim 
Convention Center, Ha// A 
Complications; Anaheim 
Convention Center, Lecture Ha// A; 
m 8:30 a.m.-l@00 a.m. 
B Acute lschemic 
Syndromes: An Interventional 
Perspective, Anaheim Convention 
Center, Lecture Hall A 1 
8~30 a.m.-lo:00 a.m. 
Novel Catheter-Based 
Imaging Methods to Assess 
Plaque Stability II, Anaheim 
Convention Center, Room 207A 
300 p.m.*00 p.m. 
IVUS: Insights Into 
Methodology and Pathogenesis, 
inaheim Convention Center, Hall / 
-esions With’ Evidence of 
Thrombosis, Anaheim Convention 
Center, Room 2126 HII 
3:OO p.m.*00 p.m. 
Restenosis: Basic 
iterventions: Miscellaneous I, 
Anaheim Convention Center, Ha// A 
esearch Ill, Anaheim Convention 
‘enter, Hall A 
B 4:OO p.m.S:OO p.m. 
m Functional Assessment 
f the Borderline Lesions, 
naheim Convention Center, 
oom 2725 z!a 
9:OO a.m.-II:00 a.m. 
Coronary Stenting: 
Outcomes, Anaheim Convention 
Center, Ha// A 
M 4:OO p.m.-k%30 p.m. 
m Controversies in 
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9:OO a.m.-II:00 a.m. 
Restenosis: Basic, 
Anaheim Convention Center, Ha// A 
rterventional Cardiology, 
naheim Convention Center, Arena 
Arterial Remodeling:Anaheim 
Convention Center, Ha// A 
m IO:30 a.m.-II:30 a.m. 
m Interventional 
tion, Anaheim 
Lecture Hall A 1 
Convention Center, 
the Interventionalist, 
Anaheim Convention Center, 
lecture Hall A2 
Approaches to Claudication, 
Anaheim Convention Center, Room 
2085 z&R 
m yo~~~~ls~aa~~t 
4fter Intervention, Anaheim Con- 
vention Center, Room 212A m 
4:OO p.m.-!%30 p.m. 
Brachytherapy for 
‘revention of Restenosis, Anaheim 
Convention Center, Room 207A 
If Platelet Function, Anaheim 
Convention Center, Room 2 7 I B 
m 
w IO:30 a.m.-Noon 
w Clinical Decision 
slaking, Anaheim Convention 
renter, Room 2 1 OA 
B IO:30 a.m.-Noon 
m Controversial Issues in 
Coronary Stenting, Anaheim 
lonvention Center, Arena 
I 
m 8:30 a.m.-10:OO a.m. . , 
m Late Breaking Clinical 
Trials II, Anaheim Convention 
Center, Arena 
m 8:30 a.m.-l&00 a.m. 
B Stents and Stent 
Crafts: Technique, Results, and 
, 
9:OO a.m.-II:00 a.m. 
Percutaneous 
9:OO a.m.-II:00 a.m. 
IVUS lnsiahts Into 
m IO:30 a.m.-Noon . I  
B New Adjunctive 
Therapy, Anaheim Convention 
Center, Lecture Ha// A 1 
IO:30 a.m.-Noon 
New Delivery 
Approaches, Anaheim Convention 
Center, Lecture Ha// A2 
Noon-2:OO p.m. 
Moderated Poster 
Session...Coronary Stenting: 
Challenging Subsets, Anaheim 
Convention Center, Hall A 
m 2:OO p.m.-3:00 p.m. 
m 31st Annual Louis F. 
ishop Lecture, Anaheim 
onvention Center, Ballroom A 
m ~:;o~;$~~~t~on 
Challenging Patient Subsets, 
Anaheim Convention Center, Arena 
Noon-2~00 p.m. 
Prognostic Indices, 
onvention Center, Ha// / 
Noon-2:OO p.m. 
Antiplatetet Therapy 
oronary Stenting, Anaheim 
Convention Center, Hall A 
Noon-2:OO p.m. 
Carotid, Renal, and 
Femoral Stenting, Anaheim 
Convention Center, Ha// A 
Noon-2:OO p.m. 
Restenosis: Basic 
:esearch IV, Anaheim Convention 
Ienter, Ha// A 
w 12:15 p.m.-l:45 p.m. 
m Optimal Atherectomy: 
urrent Indications and Uses, 
naheim Marriott, Salon B m 
w 12:15 p.m.-l:45 p.m. 
m Inoperable Coronary 
rtery Disease, Anaheim Marriott, 
a/on E Em 
2:OO p.m.-3:30 p.m. 
Risk Factors for II ^_ Aaverse uutcomes of Percu- 
taneous Coronary Intervention, 
Anaheim Convention Center, 
Lecture Ha// A 7 
2:OO p.m.*30 p.m. 
Gene Therapy: New 
Approaches to Restenosis and 
Angiogenesis, Anaheim Conven- 
tion Center, Lecture Ha// A2 
’ t 
; I 
I I 
PI 
B, 
Saphenous Vein Graft Disease, 
Anaheim Convention Center, 
Room 2 12A aa 
. hwud 2~30 p.m.-3:30 p.m. 
B My Worst Nightmares 
as an Interventionalist, Anaheim 
Convention Center, Room 212B 
m 
300 p.m.-5:OO p.m. 
Percutaneous 
Interventions-Coronary: 
Miscellaneous, Anaheim 
Convention Center, Ha// A 
3:OO p.m.-5:OO p.m. 
Coronary Stenting II, 
Anaheim Convention Center, Hall A 
3:OO p.m.-5:OO p.m. 
Percutaneous 
Interventions: Local Delivery, 
Anaheim Convention Center, Ha// A 
m 400 p.m.-5:OO p.m. 
B In-Stent Restenosis 
4naheim Convention Center, 
Room 209A aa 
400 p.m.-5:OO p.m. 
m Stenting Through 
tents: Managing Side Branch 
Complications, Anaheim Conven- 
‘on Center, Room 2095 m 
B 400 p.m.+00 p.m. 
m Lessons From 
ngioplasty Versus Surgery in 
lultivessel Disease, Anaheim 
bnvention Center, Arena 
m 4:OO p.m.S:OO p.m. 
m Getting Experience in 
eripheral Intervention: The 
asics, Anaheim Convention 
enter, Lecture Ha// A I 
400 p.m.-5:OO p.m. 
Nonfluoroscopic 
ectromechanical Mapping to 
ssess Myocardial Viability, 
vaheim Convention Center, 
‘cture Hall A2 
A! 
I AI 
Le 
(continued next page) 
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bm 5:30 p.m.-7:oo p.m. 
B Intravascular 
Ultrasound: Present and Future 
Applications, Anaheim Convention 
Center, Lecture Ha// A 7 
w 330 p.m.-7:OO p.m. 
B Treatment of In- 
Laboratory Complications After 
Percutaneous Transluminal 
Coronary Angioplasty, Anaheim 
Convention Center, Lecture Ha// A2 
m 6:oo p.m.-8:OO p.m. .  1 
B 49th Annual 
Convocation, Disney/and Hotel, 
Terrazzo Room 
m 8~30 a.m.-l&30 a.m. . . 
B ACC 2000 Meeting 
Highlights, Anaheim Convention 
Center, Arena 
8:30 a.m.-l&00 a.m. 
Coronary Brachy- 
, Anaheim Convention 
Center, Lecture Ha// A 1 
9~30 a.m.-lOzOO a.m. 
In-Stent Restenosis, 
Anaheim Convention Center, 
Lecture Ha// A2 
9:30 a.m.-IO:00 a.m. 
Carotid and Vertebral 
Stenting, Anaheim Convention 
Center, Room 207A 
m 9:OO a.m.-lOzOO a.m. . . 
B intervention in 
Chronic Total Occlusions, 
Anaheim Convention Center, 
m 
:OO a.m.-II:00 a.m. 
ercutaneous Inter- 
ventions: Miscellaneous II, 
Anaheim Convention Center, Ha// A 
9~00 a.m.-11:OO a.m. 
Coronary Stenting Ill, 
Anaheim Convention Center, Ha// A 
9:OO a.m.-II ~00 a.m. 
Clycoprotein Ilb/llla 
Receptor Blockers and 
Outcomes, Anaheim Convention 
Center, Ha// A 
9~00 a.m.-11 :OO a.m. 
Coronary Flow Reserve 
and Fractional Flow Reserve, 
Anaheim Convention Center, Hall A 
I 
Ir 
C 
B lo:30 a.m.-11:30 a.m. 
m Acute Myocardial 
lfarction, Anaheim Convention 
knter, Room 208A m 
B IO:30 a.m.-II:30 a.m. 
m Intervention in 
lultivessel Disease, Anaheim 
‘onvention Center, Room 208B 
nm 
B IO:30 a.m.-Noon 
m Late Breaking Clinical 
rials Ill, Anaheim Convention 
‘enter, Ballroom C 
B IO:30 a.m.-Noon 
m Myocardial Revascu- 
Irization/Angiogenesis, 
naheim Convention Center, 
ecture Ha// A2 
M IO:30 a.m.-Noon 
m Restenosis: New 
aradigms for Prevention and 
reatment, Anaheim Convention 
‘enter, Lecture Hall A 7 
IO:30 a.m.-Noon 
IVUS Insights Into 
leointimal Proliferation, 
naheim Convention Center, 
oom 273A 
w 12:15 p.m.-l:45 p.m. 
m Expanding Role of the 
ow Molecular Weight Heparins, 
naheim Marriott, Salon D m 
B 12:15 p.m.-l:45 p.m. 
m Acute Myocardial 
lfarction Angioplasty: When, 
vhere, Whom?, Hi/ton Anaheim, 
acific 6 ai 
Be sure to check the final 
Program onsite in Anaheim, 
for all location and program 
updates. ACC2000 
preregistrants may pick up 
portfolios and Final Programs 
at Registration in the Anaheim 
Convention Center, Hall C. 
. . q Structured Sessions 
m (Black Boxes) 
Abstract Sessions 
(Crey Boxes) 
m SessionType and . . 
m Number are shown in 
the shaded box. defer to 
the Scientific Sessions 
Key for more information about the 
type of session. Oral and Poster 
Abstract Sessions are grey shaded 
boxes; Structured Sessions are 
shown in black. 
The SessionTitle and its Location 
are listed next. 
m Some sessions require a 
Ticket and are so noted. 
Sessions listed ,within a shaded 
ar,ea are’ pat-8 of the ACXIS2000 
Spatl@h* Sunday program, and 
require the speci+l ~egistr&on 
fee,” ‘( I;, ,. 1 ’ 
Sunday, March 12 
noon-5 pm 
Monday, March 13 
9 am-5 pm 
Tuesday, March 14 
9 am-5 pm 
Wednesday, March 15 
9 am-noon 
VIII 
m 9:OO a.m.-Noon 
u! Controversial Topics in 
Pacing, Anaheim Convention 
Center, Room 273C m 
Arrhythmias and Sudden Death 
in Nonischemic Cardiomyopathy, 
Anaheim Convention Center, Room 
304A m 
Noon-2:00 p.m. 
Antiarrhythmic Drugs, 
Anaheim Convention Center, Hall A 
Noon-2:00 p.m. 
Electrocardiography: 
New insights, Anaheim 
Convention Center, Hall A 
m 2:00 p.m.-5:00 p.m. 
B Analvsis of Comolex 
Arrhythmias, Aiaheim Con;ention 
Center, Room 207A aa 
m 2:00 p.m.-5:00 p.m. 
B Nonpharmacologic 
Therapy of Atrial Fibrillation, 
Anahkim Convention Center, 
Room 304C ma 
Anaheim Convention Center, Ha// A 
m 530 p.m.-?:00 p.m. 
B Nonsustained 
Ventricular Tachycardia and 
Sudden Death, Anaheim 
Convention Center, Room 207A 
m 5:30 p.m.-7:00 p.m. 
B Management of Atrial 
Fibrillation, Anaheim Convention 
Center, Room 2 I OA 
Session, Anaheim Convention 
Center, Arena 
m 9:OO a.m.-IO:00 a.m. . . 
m Patina in Conaestive 
Heart Failure, AnGheim C&vention 
Center, Room 2 1 IA m 
9:OO a.m.-11 :OO a.m. 
Moderated Poster 
Session...Pacing for Atrial 
Fibrillation Prevention, Anaheim 
Convention Center, Ha// A 
9~00 a.m.-II:00 a.m. 
Catheter 
Ablation/Atria1 Fibrillation/Atria1 
Flutter, Anaheim Convention 
Center, Hall A 
9~00 a.m.-II:00 a.m. 
Patina and Arrhvthmia 
Mechanisms, AnGheim ConCention 
Center, Ha// A 
9:OO a.m.-II:00 a.m. 
T-Wave Alternans. 
Anaheim Convention Center, haI/ A 
w1s*l 9~15 a.m.-l&30 a.m. 
B Late Breaking Clinical 
Trials I, Anaheim Convention 
Center, Ballroom C 
9:15 a.m.-IO:30 a.m. 
Atrial Defibrillation, 
Anaheim Convenlion Center, 
Room 304C 
m IO:30 a.m.-II:30 a.m. . . 
m Medical Treatment of 
Neurocardiogenic Syncope, 
Anaheim Convention Center, 
Room 2089 m 
m II:00 a.m.-12:15 p.m. .* 
B Prevention of Sudden 
Cardiac Death, Anaheim 
Center, Ballroom C 
II:00 a.m.-12:15 p.m. 
Pacing for Congestive 
Heart Failure, Anaheim Convention 
Center, Room 304C 
Atrial Fibrillation: 
Center, Hall A 
Ablation, Anaheim Convention 
Center, Hall A 
Noon-2:00 p.m. 
QT Dispersion, 
Anaheim Convention Center, Hall A 
m 12:15 p.m.-l:45 p.m. 
%%%!r”~:r%t 
Salon E ’ ’ m 
2:00 p.m.-3:30 p.m. 
Featured Oral Abstract 
Session...Catheter-Based 
Ablation of Atrial Fibrillation, 
Anaheim Convention Center, 
Room 2 1 OA 
2:00 p.m.-3:30 p.m. 
Autonomic Nervous 
aheim Convention 
Center, Room 304C 
m 2:30 p.m.&30 p.m. 
B Optimal Coding and 
Cost-Containment in the 
Electrophysiology Lab, 
Anaheim Convention Center, 
Room 21 IA N!a 
3:OO p.m.-5:00 p.m. 
Supraventricular 
Tachycardia, Anaheim Convention 
Center, Hall A 
300 p.m.-5:00 p.m. 
Dual Chamber 
rs, Anaheim Convention 
Center Hall A 
300 p.m.*00 p.m. 
Syncope, 
Anaheim Convention Center, Ha// A 
of Implantable Cardioverter 
Defibrillators, Anaheim Convention 
Center, Room 209A m 
m 4:OO p.m.430 p.m. 
m Update on Ablation, 
Anaheim Convention Center, 
Room 2 I OA 
4~00 p.m.-5:30 p.m. 
Atrial Fibrillation/ 
Flutter: Noninvasive Risk 
Assessment, Anaheim Convention 
Center, Room 304C 
Structured Sessions 
(Black Boxes) 
Abstract Sessions 
(Grey Boxes) 
m SessionType and . . 
m Number are shown in 
the shaded box. Refer to 
the Scientific Sessions 
Key for more information about the 
type of session. Oral and Poster 
Abstract Sessions are grey shaded 
boxes; Structured Sessions are 
shown in black. 
The Session Title and its Location 
are listed next. 
m Some sessions require a 
Ticket and are so noted. 
Sunday, March 12 
noon-5 pm 
Monday, March 13 
9 am-5 pm 
Tuesday, March 14 
9 am-5 pm 
Wednesday, March 15 
9 am-noon 
Be sure to check the Final 
Program onsite in Anaheim, 
for all location and program 
updates. ACC2000 
preregistrants may pick up 
portfolios and Final Programs 
at Registration in the Anaheim 
Convention Center, Hall C. 
X 
m 9~00 a.m.-Noon 
B Optimal Use of 
Noninvasive Techniques in the 
Management of Heart Failure, 
Anaheim Convention Center, 
Lecture Hall A2 EQI 
Noon-Z:00 p.m. 
Diastolic Dysfunction 
and Heart Failure, Anaheim 
Convention Center, Ha// A 
Noon-2:00 p.m. 
Dilated Cardio- 
myopathy, Anaheim Convention 
Center, Ha// A 
Noon-Z:00 p.m. 
Heart Transplant: 
Pretransplant Issues, Anaheim 
Convent/on Center, Hall A 
m 2:00 p.m.-5:00 p.m. 
B Basic Mechanisms in 
Heart Failure: Why Does the 
Heart Fail? Implications for 
Treatment, Anaheim Marriott, 
Marquis Northwest a# 
400 p.m.-500 p.m. 
Apoptosis: 
Relationshio to Oxidative Stress 
and Myoca’rdial Failure, Anaheim 
Convention Center, Ha// A 
4:OO p.m.400 p.m. 
Cytokines and 
Natriuretic Peptides in Heart 
Failure: Diagnostic and 
Therapeutic Implications, 
Anaheim Convent/on Center, Hall A 
400 p.m.-&00 p.m. 
Determinants of 
Exercise Tolerance, Anaheim 
Convention Center, Hall A 
m 530 p.m.-7:OO p.m. 
B Experimental Models 
and Novel Investigative 
Approaches to the Study and 
Treatment of Heart Failure, 
Anaheim Convention Center, 
Room 304C 
m 8:OO a.m.400 a.m. 
w Presidential Plenary 
Session, Anaheim Convention 
Center, Arena 
m 9:00 a.m.-l&00 a.m. . . 
B ACE-Inhibitors, A-II 
Antagonists, and Beta-Blockers in 
Heart Failure: Which One(s)? 
Anaheim Convention Center, 
Room 212A ma 
9:00 a.m.-II:00 a.m. 
Cytokines and 
Endothelial Changes in 
Mvocardial Failure, Anaheim 
C&vention Centei Ha// A 
900 a.m.-11:OO a.m. 
9:00 a.m.-II:00 a.m. 
aheim Convention 
Center, Ha// A 
m 915 a.m.-IO:30 a.m. 
&& Late Breaking Clinical 
Trials I, Anaheim Convention 
Center, Ballroom C 
m 915 a.m.-l&30 a.m. . . 
B Is It Possible to 
Prevent Heart Failure? Reviewing 
the Evidence, Anaheim 
Convention Center, Ballroom A 
9:15 a.m.-10:30 a.m. 
Exercise Tolerance in 
Heart Failure, Anaheim Convention 
Center, Room 304A 
M IO:30 a.m.-11 :30 a.m. . . 
B Difficult Hemodynamic 
Dilemmas: Interpretation and 
Management, Anaheim Conven- 
tion Center, Room 212A am 
m 11:OO a.m.-12:15 p.m. . . 
B Emerging Issues in 
Transplantation, Anaheim 
Center, Ballroom A 
II:00 a.m.-G%15 p.m. 
Novel and Established 
Surgical Approaches to Heart 
Failure, Anaheim Convention 
Center, Room 304A 
Noon-Z:00 p.m. 
New Methods to 
Assess Myocardial Function, 
Anaheim Convention Center, Hall A 
Noon-200 p.m. 
Diagnosis and 
Proqnosis in Heart Failure II, 
Adheim Convention Center, Ha// A 
Noon-Z:00 p.m. 
Clinical Aspects of 
Hypertrophic Cardiomyopathy, 
Anaheim Convention Center, Hall A 
m 12:15 p.m.-l:45 p.m. 
& End-Stage Congestive 
Heart Failure: Newer Options, 
Hilton Anaheim, Pacific A m 
Failure Secondary to Pure 
Diastolic Dysfunction, Anaheim 
Convention Center, Ballroom A 
2~00 p.m.-3:30 p.m. 
Dilated and 
Hypertrophic Cardiomyopathies: 
Clinical Aspects, Anaheim 
Conventiori Center, Room 2 13A 
200 p.m.-3:30 p.m. 
Myocardial and 
Vascular Dysfunction in Elderly 
Patients, Anaheim Convention 
Center, Room 304A 
m 2~30 p.m.-3:30 p.m. 
B Myocarditis-Pericarditis, 
Anaheim Convention Center, 
Room 272A m 
300 p.m.+00 p.m. 
Diagnosis and 
n Heart Failure Ill, 
onvention Center, Ha// A 
3:00 p.m.-500 p.m. 
Cardiogenic Shock/ 
I Circulatory 
Assistance, Anaheim Convention 
/I A 
3:00 p.m.-5:00 p.m. 
Risk Factors and 
Miscellaneous Problems in the 
Elderly, Anaheim Convention 
Center, Hall A 
M 4:00 p.m.-5:00 p.m. 
h Arrhythmias in Heart 
Failure, Anaheim Convention 
Center, Room 2089 m 
m 4~00 p.m.-5:30 p.m. . . 
m Nonpharmacologic 
Approaches to Heart Failure, 
Anaheim Convention Center, 
Ballroom A 
4:OO p.m.-S:30 p.m. 
Featured Oral Abstract 
Session...Effects of Load/Unload 
Neurohumoral Activation/ 
Blockade on the Failing Heart, 
Anaheim Convention Center, 
Room 304A 
Hypertrophic Cardiomyopathies: 
Genetic Aspects, Anaheim 
Convention Center, Room 2 13A 
m SessionType and 
m Number are shown in 
Key for more information about the 
type of session. Oral and Poster 
Abstract Sessions are grey shaded 
boxes; Structured Sessions are 
shown in black. 
The SessionTitle and its Location 
are listed next. 
m Some sessions require a 
Ticket and are so noted. 
Sunday, March 12 
noon-5 pm 
Monday, March 13 
9 am-5 pm 
Tuesday, March 14 
9 am-5 pm 
Wednesday, March 15 
9 am-noon 
xi 
mw 8~30 a.m.-10:OO a.m. 
m Late Breaking Clinical 
Trials II, Anaheim Conve&on 
Center, Arena 
m 8:30 a.m.-Noon 
B Controversies in 
Cardiology, Anaheim Convention 
Center, Ballroom C 
m 8:30 a.m.-10:OO a.m. 
B Cardiac Manifestations 
af Systemic Diseases, Anaheim 
Convention Center, Room 2 1 OA 
8~30 a.m.-lOtO0 a.m. 
Insights From Heart 
ical Trials I, Anaheim 
Convention Center, Room 2 13A 
8~30 a.m.-l&00 a.m. 
Which Neurohumoral 
Mediators Really Control the 
Extracellular Matrix and Diastolic 
Function?, Anaheim Convention 
Center, Room 304A 
m 9~00 a.m.-lOzOO a.m. 
B Managing Power 
Failure Complicating Infarction, 
Anaheim Convention Center, 
Room 208A ma 
m 9:OO a.m.-IOf00 a.m. 
B Difficult Dilemmas in 
Diastology: Constriction Versus 
Restriction, Anaheim Convention 
Center, Room 2096 anz 
9:00 a.m.-1l:OO a.m. 
Evolving Concepts 
Regarding Drug Therapies for 
Heart Failure I, Anaheim 
Convention Center, Hall A 
900 a.m.-II:00 a.m. 
Miscellaneous Cardio- 
myopathies: Clinical Aspects, 
Anaheim Convention Center, Hall A 
9:00 a.m.-II:00 a.m. 
Exercise Testing, 
Anaheim Convention Center, Ha// A 
m IO:30 a.m.-II:30 a.m. 
B Heart Failure in the 
Elderly, Anaheim Convention 
Center, Room 217A an 
m 10:30 a.m.-Noon .  2 
1-q Clinical Decision 
Making, Anaheim Convention 
Center, Room 2 7 OA 
lo:30 a.m.-Noon 
Insights From Heart 
ical Trials II, Anaheim 
n Center, Room 2 7 3A 
IO:30 a.m.-Noon 
Exercise Testing to 
Determine Prognosis, Anaheim 
Convention Center, Room 304A 
Noon-Z:00 p.m. 
Signal Transduction in 
gulation, Anaheim 
Convention Center, Hall A 
NoonP:OO p.m. 
Evolving Concepts 
Regarding Drug Therapies for 
Heart Failure II, Anaheim 
Convention Center, Hall A 
Noon-Z:00 p.m* 
Predictors of Prognosis 
and Outcomes in Elderly 
Patients, Anaheim Convention 
Center, Hall A 
12:15 p.m.-l:45 p.m. 
Heart Failure: Beta- 
Blockers and Beyond, Anaheim 
Marriott, Salon F Bz 
IiRm 
12:15 p.m.-l:45 p.m. 
Managing a Patient 
After Heart Transplantation: A 
General Cardiologist’s Primer, 
Anaheim Marriott, Salon D m 
12:15 p.m.-l:45 p.m. 
How to Evaluate 
Diastolic Function in Y2K, 
Hilton Anaheim, Pacific A m 
200 p.m.-3:OO p.m. 
31 st Annual Louis 
F. Bishop Lecture, Anaheim 
Convention Center, Ballroom A 
m 
2:00 p.m.-%30 p.m. 
Ancillary Therapy in 
the Patient With Heart Failure, 
Anaheim Convention Center, 
Ballroom C 
2:00 p.m.-3:30 p.m. 
Cardiac Transplant: 
Rejection and Immuno- 
suppression, Anaheim Convention 
Center, Room 304A 
300 p.m.-5:OO p.m. 
Heart Failure 
‘athophysiology, Anaheim 
Convention Center, Ha// A 
300 p.m.-500 p.m. 
Myocarditis, 
‘ericarditis, and Myxoma, 
Anaheim Convention Center, Ha// A 
00 p.m.-5:OO p.m. 
ardiac Transplant: 
nisms, Anaheim 
Convention Center, Hall A 
m 4~00 p.m.&00 p.m. 
B lmmunosuppression 
Strategies in Heart Trans- 
Jlantation, Anaheim Convention 
Center, Room 2 12A ZEE 
4~00 p.mA:OO p.m. 
B Surgical Interventions 
n Congestive Heart Failure: 
Ievascularization, Valve Repair, 
ind Remodeling, Anaheim 
Convention Center, Room 2 12B 
m 
m 4:OO p.m.-5:OO p.m. 
B Hypertrophic 
Jbstructive Cardiomyopathy: 
idvances in Management, 
4naheim Convention Center, 
Sal/room A 
4:OO p.m.-5:OO p.m. 
Cardiogenic Shock: 
Vew Insights and Approaches, 
4naheim Convention Center, 
Poem 304A 
m 5:30 p.m.-7:OO p.m. 
B The Management of 
Zonqestive Heart Failure in a 
Managed Care Environment, 
4naheim Convention Center, 
Soom 207A 
m 6:00 p.m.-S:00 p.m. 
B 49th Annual 
Convocation, Disneyland Hotel, 
Terrazzo Room 
Be sure to check the Final 
Program onsite in Anaheim, 
for all location and program 
updates. ACC2000 
preregistrants may pick up 
portfolios and Final Programs 
at Registration in the Anaheim 
Convention Center, Hall C. 
m 8~30 a.m.-KC30 a.m. 
w ACC 2000 Meeting 
iighlights, Anaheim Convention 
Ienter, Arena 
8~30 a.m.-WOO a.m. 
Adjunctive Non-Drug 
-herapies for Heart Failure, 
3naheim Convention Center, 
loom 304A 
m 9:OO a.m.-IO:00 a.m. 
B Ventricular Assist 
Devices, Anaheim Convention 
renter, Room 2 I ?A aa 
9~00 a.m.-II:00 a.m. 
Moderated Poster 
ardiac Function in 
iealth and Disease, Anaheim 
9:00 a.m.-11 :OO a.m. 
:ailure, Anaheim Convention 
Center, Ho/l A 
9:OO a.m.-II:00 a.m. 
Heart Failure Diagnosis 
md Disease Management, 
lnaheim Convention Center, Hall A 
9:00 a.m.-11 ~00 a.m. 
Heart Transplant: Graft 
%nction, Anaheim Convention 
Center, Ha// A 
m IO:30 a.m.-II:30 a.m. 
B How to Use Beta- 
3lockers in Congestive Heart 
-ailure, Anaheim Convention 
Center, Room 2 7 7 A m 
m lo:30 a.m.-Noon 
B Late Breaking Clinical 
Trials Ill, Anaheim Convention 
Center, Ba//room C 
m IO:30 a.m.-Noon 
B Managing Congestive 
ieart Failure: Which Drugs, in 
Nhich Sequence, in Which 
‘atients?, Anaheim Convention 
Center, Ballroom A 
IO:30 a.m.-Noon 
Newer Agents for 
Heart Failure, Anaheim Convention 
Center, Room 304A 
m 1215 p.m.-l:45 p.m. * 
B Mitral Requrqitation 
and Left Ventricular by&nction, 
Hi/ton Anaheim, Laguna m 
m 12:15 p.m.-l:46 p.m. 
B Hypertrophic 
Obstructive Cardiomyopathy, 
Anaheim Marriott, Salon E m 
xii 
m 9:OO a.m.-Noon 
B Targeting the 
Endothelium, Anaheim Marriott, 
Marquis Northeast m 
NoonS:OO p.m. 
Vascular Biology: 
Clinical and Experimental I, 
Anaheim Convention Center, Hall A 
Noon-2:00 p.m. 
Mechanisms and 
Treatment of Endothelial 
Dysfunction, Anaheim Convention 
Center, Hall A 
Noon-2:00 p.m. 
Treatment of Post 
Catheterization Vascular 
Complications, Anaheim 
Convention Center, Hall A 
Noon-2:00 p.m. 
Treatment of 
Hypertension, Anaheim 
Convention Center, Hall A 
m 2:00 p.m.-5:OO p.m. 
m Cardiovascular Disease 
‘revention in the Insulin-Resistant 
‘atient, Anaheim Convention 
Center, Room 213C m 
4:OO p.m.b:OO p.m. 
Cardiovascular 
sic Studies, Anaheim 
Convention Center, Ha// A 
4~00 p.m.-900 p.m. 
Newer Therapies in 
ular Disease, Anaheim 
Convention Center, Hall A 
4:00 p.m.-900 p.m. 
Benefits of Lipid 
-owering, Anaheim Convention 
Center, Hall A 
m 5:30 p.m.-7:OO p.m. 
B The Noninvasive 
Vascular Laboratory, Anaheim 
Marriott, Marquis Northeast 
m 5:30 p.m.-7:OO p.m. 
m Achievinq Optimal 
Risk Reduction Outcomes in 
Cardiovascular Prevention, 
Anaheim Marriott, Marquis 
Northwest 
m 9:OO a.m.-g:00 a.m. .  1  
B Presidential Plenary 
Session, Anaheim Convention 
Center, Arena 
m 900 a.m.-IO:00 a.m. . 
!!!EE!To~~~~~~~s~~~~sesf 
Room 208A ‘Ita 
9:00 a.m.-II:00 a.m. 
Human Genetics and 
ular Disease, Anaheim 
Convention Center, Hall A 
9:00 a.m.-1l:OO a.m. 
Autonomic Regulation 
ulation and Coronary 
Blood Flow, Anaheim Convention 
/I A 
9100 a.m.-II:00 a.m. 
Vascular Biology: 
Signaling Pathways and Lipids, 
Anaheim Convention Center, Hall A 
9:00 a.m.-1l:OO a.m. 
Metabolic 
Abnormalities and Obesity: 
Relationships to Hypertension, 
Anaheim Convention Center, Hall A 
m 9:15 a.m.-lo:30 a.m. 
eq Late Breaking Clinical 
Trials I, Anaheim Convention 
Center, Ballroom C 
n . . 9:15 a.m.-10:30 a.m. 
B Why Don’t We Do It 
Better? Prevention in Cardiology 
Practice, Anaheim Marriott, 
Marquis Center 
9:15 a.m.-l&30 a.m. 
Thrombosis: Clinical 
Investigation, Anaheim Marriott, 
Marquis Northeast 
9:15 a.m.-l&30 a.m. 
Outcomes Evaluation 
oronary Syndromes, 
Anaheim Marriott, Marquis 
IO:30 a.m.-II:30 a.m. 
Intermittent Claudica- 
erapeutic Options, Anaheim 
Converition Center, Room 208A m 
11:00 a.m.-12:15 p.m. 
Molecular Cardiology: 
Vascular Injury and Cardio- 
protection, Anaheim Marriott, 
Marquis Northeast 
II:00 a.m.-12:15 p.m. 
Neurohormones and 
Advances in Hypertension and 
Heart Failure, Anaheim Marriott, 
Marquis Northwest 
Noon-2:00 p.m. 
Endothelial Dysfunction, 
onvention Center, Hall A 
Noon-2:00 p.m. 
Inflammation and 
Related Determinants of 
Atheroscleroric Plaque: Clinical 
Studies, Anaheim Convention 
Center, Hall A 
Noon-2:00 p.m. 
Aortic Dissection 
ural Hematomas, 
Anaheim Convention Center, Hall A 
Noon-2:00 p.m. 
Vascular Biology: 
Clinical and Experimental II, 
Anaheim Convention Center, Hall A 
m 12:15 p.m.-l:45 p.m. 
B Assessment of 
Endothelial Function, Hi/ton 
Anaheim, Pales Verdes #ia 
m 12:15 p.m.-l:45 p.m. . 
B Renal Artery Stenosis: 
When and How to Treat, Hilton 
Anaheim, Laguna m 
. . - 2~00 p.m.-330 p.m. 
B Emerging Risk Factors 
‘or Atherosclerosis and Their 
Treatment. Anaheim Marriott, 
k4arquis C&ter 
2~00 p.m.-3:30 p.m. 
Cardiovascular Gene 
Therapy, Anaheim Marriott, 
Marquis Northeast 
m 2~30 p.m.3:30 p.m. 
B Rational Therapy for 
Hypertension, Anaheim Conven- 
lion Center, Room 209A m 
3:00 p.m.-5:OO p.m. 
Thrombosis/Vascular 
asic, Anaheim 
Convention Center, Hall A 
3:00 p.m.-5:OO p.m. 
Epidemiology and 
Outcomes of Atherosclerosis and 
Peripheral Arterial Disease, 
Anaheim Convention Cent& Hall /: 
3:00 p.m.-500 p.m. 
Pulmonary 
Hypertension: Mechanisms and 
Response to Treatment, 
Anaheim Convention Center, Hall 1 
m 4~00 p.m.-5:OO p.m. . . 
B Statins, Niacin, or 
Fibrates?, Anaheim Convention 
Center, Room 208A nm 
m 400 p.m.-5:30 p.m. . . 
m Diabetes and the 
Heart: The Emerging Epidemic, 
Anaheim Marriott, Marquis Center 
4~00 p.m.-5:30 p.m. 
Endothelial Function, 
arriott, Marquis 
Northeast 
4:OO p.m.-5:30 p.m. 
Prognostic 
Implications of Cardiovascular 
Risk Factors, Anaheim Marriott, 
Marquis Northwest 
m SessionType and .* 
m Number are shown in 
the shaded box. Refer to 
the Scientific Sessions 
Key for more information about the 
type of session. Oral and Poster 
Abstract Sessions are grey shaded 
boxes; Structured Sessions are 
shown in black. 
The SessionTitle and its Location 
are listed next. 
m Some sessions require a 
Ticket and are so noted. 
Sunday, March 12 
noon-5 pm 
Monday, March 13 
9 am-5 pm 
Tuesday, March 14 
9 am-5 pm 
Wednesday, March 15 
9 am-noon 
B 8:30 a.m.-l&00 a.m. 
w Late Breaking Clinical 
rials II, Anaheim Convention 
‘enter, Arena 
B 8:30 a.m.-Noon 
m Controversies in 
:ardioiogy, Anaheim Convention 
‘enter, Baliroom C 
8:30 a.m.-IO:00 a.m. 
Endothelial Regulation 
f Vascular Tone in Humans, 
naheim Marriott, Marquis 
lortheast 
8:30 a.m.-IO:00 a.m. 
Prognosis in 
lypertension: Lessons From the 
najor Studies, Anaheim Marriott, 
/Marquis Northwest 
B 9~00 a.m.-‘IO:00 a.m. 
m Hyperlipidemia in the 
‘oung: What Is It and What Do 
‘ou Do About It?, Anaheim 
Convention Center, Room 2085 
m 
-. , r~atnopnysrorogrc Lorrerares, 
m 12:15 p.m.-l:45 p.m. Anaheim Convention Center, Hall A 
m Hormone Therapy and 
Coronary Artery Disease: 
4~00 p.m.-5:OO p.m. 
Controversies and Current 
’ m Hypertension 2000, 
Practices. Hi/ton Anaheim. 
Anaheim Marriott, Marquis Center 
9:OO a.m.-II:00 a.m. 
Vascular Biology: 
aheim Convention 
/I A 
Huntington =; 4:OO p.m.-500 p.m. 
m 12:15 p.m.-l:45 p.m. 
Mechanisms and 
m Hypertension: JNC 6, 
Treatment of Pulmonary 
Anaheim Marriott, Salon 1 m 
Hypertension, Anaheim Marriott, 
Marquis Northeast 
9:OO a.m.-II ~00 a.m. 
Genetics, Gene 
i-ansfer, and Vascular Function, 
Anaheim Convention Center, Hall A 
m 12:15 p.m.-l:45 p.m. 
m Aottic Aneurysms: 
Diagnostic and Therapeutic 
Considerations, Hi/ton Anaheim, 
Capistrano m m 5:30 p.m.-7:OO p.m. m Small LDL, IDL, and 
9~00 a.m.-II:00 a.m. HDLZ: Should Cardiologists Use 
Distensibility of the These Measurements?, Anaheim 
Peripheral Arteries in 
Diseased States, Anaheim 
Marriott, Marquis Northwest 
Convention Center, Hall A 
m 530 p.m.-7:OO p.m. 
Bishop Lecture, Anaheim 
B Psychosocial Factors 
9:00 a.m.-II:00 a.m. 
Miscellaneous Topics: Convention Center, Ballroom A 
I and Coronary Disease: Causal 
Relationships and Risk, Anaheim 
Lipids and Cardiovascular m 2:00 p.m.-3:30 p.m. Marriott, Marquis Northeast 
Ri;$;naheim Convention Center, I(;icjl What Is New in Lipid . 
Lowering Therapy?, Anaheim 
m 5~00 p.m.-8:00 p.m. 
Marriott, Marquis Center 
6 49th Annual 
m 10~30 a.m.-Noon 
B Sexual Activity and the 
Convocation, Disney/and Hotel, 
2:00 p.m.-3:30 p.m. Terrazzo Room 
Cardiovascular System, Anaheim Vascular Biology, 
Angiogenesis, and Myocardial 
Function, Anaheim Convention 
Center, Ha// A 
3:00 p.m.S:OO p.m. 
Mechanisms and 
Eoidemioloav of Stroke, Anaheim 
Noon-2:00 p.m. Convention Tenter, Hall A 
Antiplatelet 
herapy and 
300 p.m.-5:OO p.m. 
Anticoagulant Monitoring, 
Innovative Diagnostic 
Anaheim Convention Center, Hall A 
and Therapeutic Approaches to 
Thromboembolism, Anaheim 
Noon-2:00 p.m. Convention Center, Hall A 
Lipoproteins: New 
eim Convention Center, 
3~00 p.m.-S:00 p.m. 
Hd A 
Hypertension: .I .,.- I. 
Marriott, Marquis Center 
IO:30 a.m.-Noon 
Featured Oral Abstract 
mportant Results, 
Important Drugs, Anaheim 
Marriott Marquis Northwest 
lo:30 a.m.-Noon 
Vascular Inflammation, 
Calcification, and Matrix 
Metalloproteinases: Implications 
for Atherosclerotic Events, 
Anaheim Marriott, Marquis 
Northeast 
Anaheim Marriott, Marquis 
Northeast 
2:00 p.m.330 p.m. 
Infection, 
Inflammation, and Coronary 
Artery Disease, Anaheim Marriott, 
Marquis Northwest 
m 2~30 p.m.3:30 p.m. . . 
B EBCT: How Should 
It Be Used Clinically, Anaheim 
Convention Center. Room 208B 
Be sure to check the Final 
Program onsite in Anaheim, 
for all location and program 
updates. ACC2000 
preregistrants may pick up 
portfolios and Final Programs 
at Registration in the Anaheim 
Convention Center, Hall C. 
8~30 a.m.-l&30 a.m. 
ACC 2000 Meeting 
Highlights, Anaheim Convention 
Center, Arena 
8:30 a.m.-IO:00 a.m. 
Outcomes and Effect 
of Treatment of Aortic, Peripheral, 
and Cerebrovascular Disease, 
Anaheim Marriott, Marquis 
Northeast 
8:30 a.m.-%45 a.m. 
Drug Therapy of 
yperlipidemia: Clinical Benefits, 
naheim Marriott, Marquis 
‘orthwest 
9:OO a.m.-lOzOO a.m. 
How Important Are 
DL Cholesterol and Trigly- 
erides? Anaheim Convention 
enter, Room 2088 mz 
9100 a.m.-11:OO a.m. 
Atherosclerosis: 
athophysiology-Clinical, 
naheim Convention Center, Hall A 
9:00 a.m.-1l:OO a.m. 
Conventional Therapy 
f Coronary Artery Disease: New 
jata, Anaheim Convention Center, 
/a// k 
9:OO a.m.-U:00 a.m. 
Inflammation and 
ipoproteins, Anaheim Convention 
Yenter, Hall A 
9:00 a.m.-VI:00 a.m. 
Hypertension: 
vliscellaneous Observations, 
4naheim Convention Center, Hall A 
m E;f;m.-II:30 a.m. 
Thromboembolism and 
Pulmonary Hypertension, 
4naheim Convention Center, 
Room 209B m 
@J!= 
lo:30 a.m.-Noon 
Late Breaking Clinical 
Trials Ill, Anaheim Convention 
Center, Ballroom C 
10~30 a.m.-Noon 
Diagnosis and 
Management of Peripheral 
Arterial Disease (PAD), 
Anaheim Marriott, Marquis Center 
lo:30 a.m.-Noon 
Determinants of 
Clinical Outcomes in 
Hypertension, Anaheim Marriott, 
Marquis Northeast 
xiv 
m 9:00 a.m.-Noon 
m Rest Angina Without 
ST-Seqment Elevation: Contem- 
porary Management, Anaheim 
Convention Center, Room 2 13A 
m 
Noon-2:00 p.m. 
Myocardial Infarction: 
Inflammation and Plaque 
Vulnerability, Anaheim Convention 
Center, Hall A 
Noond:OO p.m. 
Coronary Artery 
Disease: PrognosticFeatures, 
Anaheim Convention Center, Hall A 
Noon-2:00 p.m. 
Cardiac Surgery: New 
Techniques, Risk Factors, and 
Surgical Outcomes, Anaheim 
Convention Center, Hall A 
m 2~00 p.m.-5:OO p.m. 
m New Management 
Concepts During the Early Hours 
of Infarction, Anaheim Convention 
Center, Room 2 7 OA ma 
Common to Cardiac Surgery and 
Cardiology, Anaheim Convention 
Center, Room 304A aa 
4~00 p.m.-6:OO p.m. 
Antiplatelet and 
Antithrombim Therapies for 
Acute Coronary Syndromes, 
Anaheim Convention Center, Hall A 
4~00 p.m.b:OO p.m. 
Novel Approaches to 
the Management of Acute 
Coronary Syndromes, Anaheim 
Convention Center, Hall A 
4:OO p.m.-&00 p.m. 
Coronary Syndromes 
in Patients With lnsiqnificant 
Fixed Coronary Obsiruction, 
Anaheim Convention Center, Hall A 
m 5:30 p.m.-7:OO p.m. 
B lschemic Cardiomyo- 
pathy: When to Revascularize, 
Hilton Anaheim, Pacific C 
m 5~30 p.m.-7:OO p.m. 
Ic;i* Choices in Myocardial 
Stress Imaging: What Test? For 
Which Patient?, Hi/ton Anaheim, 
California C 
W 5:30 p.m.-7:OO p.m. 
B Modern Antithrombin 
Therapy, Anaheim Convention 
Center, Room 2 13C 
v 5:30 p.m.-7:OO p.m. 
B Optimal Treatment 
Following Acute Myocardial 
Infarction, Anaheim Marriott, 
Marquis Center 
m 8100 a.m.-9:00 a.m. . 
B Presidential Plenary 
Session, Anaheim Convention 
Center, Arena 
m 9:00 a.m.-Ku00 a.m. . 
B Management of the 
Patient With Non-Q-Wave 
Myocardial Infarction, Anaheim 
Convention Center, Room 209A 
SE 
900 a.m.-II:00 a.m. 
Myocardial Infarction: 
Determinants of Remodeling, 
Anaheim Convention Center, Hall A 
9:00 a.m.-II :OO a.m. 
Contemporary 
Management of Acute 
Myocardial Infarction, Anaheim 
Convention Center, Ha// A 
9:OO a.m.-II:00 a.m. 
Special Topics in 
Stable Angina, Anaheim 
Convention Center, Ha// A 
Trials I, Anaheim Convention 
Center, Ballroom C 
9:16 a.m.-l&30 a.m. 
Featured Oral Abstract 
Session...Innovative Techniques 
in Cardiac Surgery-The Pump: 
Friend or Foe, Anaheim 
Convention Center, Room 2 7 3C 
M IO:30 a.m.-II:30 a.m. . . 
B How and When to 
Treat Silent Ischemia, Anaheim 
Convention Center, Room 209A 
m 
m 11 :OO a.m.-Noon . . 
B Evolving Concepts 
in Stable Coronary Disease, 
Anaheim Marriott, Marquis Center 
II:00 a.m.-12:15 p.m. 
Myocardial infarction: 
nd the Role of Growth 
Factors, Anaheim Convention 
Center, Room 2 13A 
II:00 a.m.-1215 p.m. 
Therapeutic Strategies 
for Acute Coronary Syndromes, 
Anaheim Convention Center, 
Room 213C 
Noon-2:00 p.m. 
Moderated Poster 
Session...lnfection, 
Inflammation, and the Hot 
Plaque, Anaheim Convention 
Center, Hall A 
Noon-2:00 p.m. 
Acute Coronary 
Syndromes: Significance of 
Serum Markers, Anaheim 
Convention Center, Hall A 
Noon-2:00 p.m. 
Mechanical 
Revascularization in Acute 
Myocardial Infarction, Anaheim 
Convention Center, Hall A 
Noon-200 p.m. 
Enzymatic and 
Seroloqical Markers of Outcome 
in Acufe Coronary Syndromes, 
Anaheim Convention Center, Hall A 
m 12:15 p.m.-l:45 p.m. * 
EI! Emerqency Revas- 
cularization for Acute Myocardial 
Infarction, Anaheim Marriott, 
Salon 3 m 
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m 8:30 a.m.-10:OO a.m. 
B Late Breaking Clinical 
Trials II, Anaheim Convention 
Center, Arena 
5~30 a.m.-l&05 a.m. 
Featured Oral Abstract 
Session...Adult Congenital Heart 
Disease II, Hi/ton Anaheim, Colifomia A 
m ;y;m.;;:~.;;~. 
and Automatic Defibrillators in 
Pediatric Patients, Anaheim Con- 
vention Center, Room 21 JB m 
9:OO a.m.-1l:OO a.m. 
Moderated Poster 
Session...Pediatric Cardioloqy/ 
Congenital Heart Disease, -- 
Anaheim Convention Center, Hall A 
900 a.m.-11 :OO a.m. 
Pediatric Acquired 
Heart Disease: Kawasaki, Cardio- 
myopathy, and Connective Tissue 
Disorders, Anaheim Convention 
Center, Ha// A 
m lo:30 a.m.-II:30 a.m. . . 
B How to Perform and 
Interpret Transesophageal 
Echocardioaraphv in Conqenital 
Heart Disea<e,‘Aiaheim C&ven- 
tion Center, Room 2 I25 m 
m IO:30 a.m.-Noon 
B Controversies in Pediatric 
Cardiology, Hi/ton Anaheim, Pacific C 
Noon-2:00 p.m. 
q Pediatric Arrhythmias, 
Anaheim Convention Center, Hall A 
I 1215 p.m.-l:45 p.m. 
m 2:00 p.m.430 p.m. .  & 
B Pediatric Cardiology 
Clinical Decision Making, 
Hilton Anaheim, Pacific C 
m 2~30 p.m.430 p.m. 
&& Syncope: Evaluation 
and Management in Pediatric 
Patients, Anaheim Convention 
Center, Room 2 17 5 m 
300 p.m.-5:OO p.m. 
Fetal and Neonatal 
Cardiology, Anaheim Convention 
Center, Hall A 
m 4~00 p.m.-5:OO p.m. . . 
B Use of Stents in Pedia- 
tric Cardiology, Anaheim Conven- 
tion Center, Room 208A aa 
Evaluation, Treatment, and 
Prevention in Pediatric Patients, 
Hi/ton Anaheim, Pacific C 
5:30 p.m.-7:OO p.m. 
Catheter Interven- 
tional Closure of ASD and VSD, 
Anaheim Convention Center, 
Room 2 13A 
5:30 p.m.-7:OO p.m. 
Fetal Heart Disease: 
Diagnosis and Management, 
Anaheim Convention Center, 
Room 2 7 3C 
I’ar,eno ““lUl L 
Disease, Anahei 11, L”,,“C,,LI”II 
Center. Room 304C 
5~30 p.m.-7:OO p.m. 
Arrhythmias in 
n-L.-.-l- \1,:11- r ongenital Heart 
‘- rr\n.mn+;,Tn 
l Diagnosis, Treatment, 
and Long-Term Follow-Up of 
Coronary Abnormalities in 
d 6:OO p.m.-800 p.m. 
. 49th Annual 
C$/Air;n, Anaheim Marriott, Convocation, Disneyland Hotel, 
ml Terrazzo Room 
1;11$*r 8:30 a.m.-l&30 a.m. 
B ACC 2000 Meeting 
Highlights, Anaheim Convention 
Center, Arena 
8:30 a.m.-IO:00 a.m. 
Pediatric Interven- 
tional Catheterization III, 
Hi/ton Anaheim, California A 
9:OO a.m.-1l:OO a.m. 
Pediatric Cardiology, 
Anaheim Convention Center, Hall A 
Late Breaking Clinical 
Trials Ill, Anaheim Convention 
Center, Ballroom C 
Congenital Heart Surgery in 
Patients Followed as Adults, 
Hi/ton Anaheim, Pacific C 
m 12:15 p.m.-l:45 p.m. . 
B Use of the Ross 
Procedure in Pediatric Patients, 
Hi/ton Anaheim, Pacific A m 
i 
i 
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v 
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Convention Center, Hall C. 
xv 
m 2:30 p.m.3:30 p.m. 
200 p.m.330 p.m. 
Infection, Infarction, 
m How to Evaluate Rest 
nd Plaque Stability, Anaheim 
Ionvention Center, Room 2?3C 
m 200 p.m.-!%30 p.m. 
ingina in the Emergency Room, 
B Joint Symposium: 
uropean Society of Cardiology/ 
Anaheim Convention Center, 
imerican College of Cardiology 
-Acute Coronary Syndromes . . 
loom 2 125 
:rom Mechanisms to Thera- 
n5i 
leutics, Anaheim Convention 
lenter, 5allroom C 
m 8:30 a.m.-IO:00 a.m. . . 
m Late Breaking Clinical 
Trials II, Anaheim Convention 
Center, Arena 
m 8:30 a.m.-Noon 
m Controversies in 
Cardiology, Anaheim Convention 
Center, Ballroom C 
m 8~30 a.m.-lOzOO a.m. . . 
B Management of the 
Patient With Chest Pain, 
Hilton Anaheim, Pacific t 
3~00 p.m.-5:OO p.m. 
Myocardial Infarction: 
schemia, Reperfusion, and 
vlyocardial Preservation, Anaheim 
Convention Center, Hall A 
3~00 p.m.-5:OO p.m. 
Use of Glycoprotein 
ibitors and Anti- 
:hrombus in Acute Coronary 
Syndromes, Anaheim Convention 
Center, Hall A 
m 4~00 p.m.-%00 p.m. 
B Assessment of 
Vlyocardial Viability With Single 
Jhoton Emission Computed 
Tomography, Anaheim Convention 
Center, Room 2 11 B WI 
4~00 p.m.-%30 p.m. 
Predictors of Mortality 
Following Acute Coronary 
Syndrome, Anaheim Convention 
Center. Room 2 13C 
m 900 a.m.-IOr00 a.m. 
h Managing Power 
8~30 a.m.-IO:00 a.m. 
Failure Complicating Infarction, 
Anaheim Convention Center, 
Treatment in the Early 
Room 208A 
Hours of Acute Myocardial 
m 
9:00 a.m.-II :OO a.m. 
Infarction, Anaheim Convention 
Ischemia, Reperfusion, 
and Myocardial Preservation, 
Anaheim Convention Center, Ha// A 
Center, Room 2 13C 
Noon-2:00 p.m. 
C-Reactive Protein and 
Acute Ischemia, Anaheim 
Convention Center, Hall A 
Noon-2:00 p.m. 
E idemiology and 
Pathophysio o 
p% 
y of Acute 
Coronary Syn romes, Anaheim 
Convention Center, Hall A 
Noon-2:00 p.m. 
Altering the Outcome 
owing Acute lschemic 
Syndromes, Anaheim Convention 
Center, Hall A 
m 12~15 p.m.-l:45 p.m. 0 
B Conservative Versus 
Invasive Strategies After 
Myocardial Infarction, Hilton 
Anaheim, Pacific 5 Ii& 
m 2~00 p.m.-3:OO p.m. 
m 31 st Annual Louis F. 
Bishop Lecture, Anaheim 
Convention Center, Ballroom A 
m 2:00 p.m.3:30 p.m. 
B Assessment of the 
Patient Following Myocardial 
Infarction, Anaheim Convention 
m 207A 
I 200 p.m.-3:30 p.m. 
Role of Clycoprotein 
8 Ilb/llla Inhibition in Acute 
9:00 a.m.-1l:OO a.m. 
Acute Coronary 
s in the Emergency 
Room, Anaheim Convention 
Center, Hall A 
9:00 a.m.-II:00 a.m. 
Cardiac Surgery: Risk 
Factors/Modification, Anaheim 
Convention Center, Ha/i A 
m IO:30 a.m.-II:30 a.m. 
B How to Administer CP 
lib-llla Receptor Antagonists, 
Anaheim Convention Center, 
Room 208A aa 
m IO:30 a.m.-Noon 
v Clinical Decision 
Making, Anaheim Convention 
Center, Room 2 7 OA 
m lo:30 a.m.-Noon . . 
B Recognition and 
Optimal Treatment of lschemic 
Left Ventricular Dysfunction, 
Hi/ton Anaheim, California C 
IO:30 a.m.-Noon 
New Insights Into 
Pathophysiology of lschemic 
Syndromes, Anaheim Convention 
Center, Room 207A 
IO:30 a.m.-Noon 
Complications of 
Acute Myocardial Infarction, 
Anaheim Convention Center, 
Room 213C 
Coronary Syndromes, Anallefm 
Conventron Center, Room 2?3C 
3:00 p.m.-5:OO p.m. 
Myocardial Infarction: 
Miscellaneous Topics, Anaheim 
Convention Center, Ho/l A 
300 p.m.-5:OO p.m. 
Novel Techniques to 
ents With an Acute 
Coronary Syndrome, Anaheim 
Convention Center, Hall A 
3:00 p.m.S:OO p.m. 
Cardiopulmonary 
on and Emergency 
Cardiac Care, Anaheim 
Convention Center, Hall A 
m 4~00 p.m.-5:OO p.m. 
Lw; How to Administer 
Thrombolytic Therapy Properly, 
Anaheim Convention Center, 
RoomZllB ED 
m 4~00 p.m.-%00 p.m. .I 
B Assessment of 
lschemic Heart Disease: Are There 
Gender Differences?, Anaheim 
Center, Room 207A 
400 p.m.-5:OO p.m. 
Advances in the 
Management of Cardiac Arrest, 
Anaheim Convention Center, 
Room 2J3C 
Noon-2:00 p.m. 
Myocardial Infarction: 
Plasma Markers and Prognostic 
Studies, Anaheim Convention 
Center, Hall A 
w1s*l6:00 p.m.-8:00 p.m. 
B 49th Annual 
Convocation, Disneyland Hotel, 
Terrazzo Room 
. m 8~30 a.m.-W30 a.m. 1 ACC 2000 Meeting 
Ihlights, Anaheim Convention 
lter, Arena 
8~30 a.m.-10:OO a.m. 
Myocardial Infarction: 
hernia and Repetfusion, 
gheim Convention Center, 
3rn 213A 
lscl 
An1 
Rot 
8~30 a.m.-l&00 a.m. 
Revascularization 
erventions in Acute Myocardial 
arction, Anaheim Convention 
rater, Room 213C 
Inf, 
Cei 
I 
for 
FOI 
co 
m 9:OO a.m.-10:OO a.m. . Primary Angioplasty 
Acute Myocardial Infarction: 
r Whom and How?, Anaheim 
nvention Center, Room 208A 
m 
m.-II:00 a.m. 
Cd mnvention Center, Hall A 
9:00 a.m.-II:00 a.m. 
Therapeutic 
xrsiderations for Stable Angina, 
laheim Convention Center, Hall A 
cc 
An 
3 
Tri 
CE 
. . . 
i!m 
IO:30 a.m.-Noon 
‘ : Late Breaking Clinical 
als Ill, Anaheim Convention 
snter, Ballroom C 
IO:30 a.m.-Noon 
Acute Coronary 
ndromes: Predictors of 
&come, Anaheim Convention 
wter, Room 2 J 3C 
. m 12:15 p.m.-l:45 p.m. New Concepts in the 
anagement of Unstable Angina 
rd Non-Q-Wave infarction, 
laheim Marriott, Salon F m 
Be sure to check the Final 
Proqram onsite in Anaheim, 
for all location and program 
uadates. ACC2000 
preregistrants may pick up 
portfolios and final Programs 
at Registration in the Anaheim 
Convention Center, Hall C. 
xvi 
m 9:OO a.m.-Noon 
B Clinical Applications 
of Cardiac Magnetic Resonance 
Imaging, Anaheim Marriott, 
Marquis Northwest m 
Noon9:OO p.m. 
Myocardial Contrast 
Echocardiography: Clinical 
Experience, Anaheim Convention 
Center, Hall A 
Tomography/Magnetic 
Resonance Imaging: Coronary 
Imaging, Anaheim Convention 
Center, Hall A 
Noon-2:00 p.m. 
Stress Myocardial 
Perfusion Imaging: Diagnosis and 
Prognosis, Anaheim Convention 
Center, Ha// A 
Be sure to check the final 
Program onsite in Anaheim, 
for all location and program 
updates. ACC2000 
preregistrants may pick up 
portfolios and Final frograms 
at Registration in the Anaheim 
Convention Center, Hall C. 
m 2:00 p.m.-5:00 p.m. 
B Nuclear Cardiology in 
Patients With Coronary Artery 
Disease: An Evidence-Based - 
Approach to Diagnosis and 
Prognosis, Anaheim Marriott, 
Marquis Northeast na 
4:OO p.m.-6:OO p.m. 
Echo-Doppler 
Assessment of Myo&rdial 
Function and Viability, Anaheim 
Convention Center, Ha// A 
4:OO p.m.*00 p.m. 
Stress Echo: Perfusion 
and Functional Correlates, 
Anaheim Convention Center, Hall A 
4~00 p.m.b:OO p.m. 
Tissue Doppler Imaging, 
Anaheim Convention Center, Ha// A 
m 5:30 p.m.-7:OO p.m. 
B lschemic Cardiomyo- 
pathy: When to Revascularize, 
Hi/ton Anaheim, Pacific C 
m 530 p.m.-7:OO p.m. 
B Choices in Myocardial 
Stress Imaging: What Test? For 
Which Patient?, Hilton Anaheim, 
California C 
w1s*l 6~00 a.m.-g:00 a.m. 
m Presidential Plenary 
Session. Anaheim Convention 
Center, ‘Arena 
m 9:OO a.m.-lo:00 a.m. . 
B Newer Applications in 
Nuclear Cardiology, Anaheim Con- 
vention Center, Room 2 I 7 B m 
m 9:00 a.m.-IO:00 a.m. . 
m Diastolic Function: How 
to Use Tissue Doppler and Flow 
Propagation, Anaheim Convention 
Center, Room 209B m 
9:OO a.m.-II:00 a.m. 
Myocardial Contrast 
Echocardiography, Anaheim 
Convention Center, Ha// A 
9:00 a.m.-II:00 a.m. 
Cardiac Magnetic 
Resonance Imaging: Left 
Ventricular Size and Function, 
Anaheim Convention Center, Ha// A 
9:OO a.m.-II :OO a.m. 
Radionuclide Assess- 
ment of Myocardial Viability, 
Anaheim Convention Center, Hall A 
m 9~16 a.m.-IO:30 a.m. . 2 
v Late Breaking Clinical 
Trials I. Anaheim Convenrion 
Center;’ Ballroom C 
9:15 a.m.-l&30 a.m. 
Stress Echo: Advances 
ation, Hilton Anaheim, 
9~15 a.m.-10:30 a.m. 
Computed Tomography/ 
Magnetic Resonance Imaging: 
Imaging Atherosclerosis, 
Hilton Anaheim, Pacific D 
M IO:30 a.m.-II ~30 a.m. . 
m Valvular Heart Disease: 
Why to Cath in Y2K, Anaheim 
Convention Center, Room 2 11 B 
m 
m IO:30 a.m.-11:30 a.m. . 
B Magnetic Resonance 
Imaging in Cardiology, Anaheim 
Convention Center, Room 209B B 
m II:00 a.m.-12:15 p.m. 
v Contrast Echocardio- 
graphy: A Practical Approach, 
Hilton Anaheim, California C 
II:00 a.m.-12:15 p.m. 
Transesophageal 
Echocardiography: Assessment of 
Left Atrial Structure and Function, 
New Applications 
Hi/ton Anaheim, Pacific D 
of 
Three-Dimensional Echocar- 
NoonP:OO p.m. 
New Doppler 
Techniques, Anaheim Convention 
Center, Hall A 
=@g 
12:15 p.m.-l:45 p.m. 
Optimal Evaluation 
and Management of the 
Asymptomatic Patient at High 
Risk for Coronary Artery Disease, 
Hilton Anaheim, Pacific B m 
12:15 p.m.-l:45 p.m. 
Evaluation of Chest 
Pain in the Emergency Room, 
Anaheim Marriott, Salon I m 
2~00 p.m.3:30 p.m. 
Nuclear Cardiologic 
Techniques: Reducing Hospital 
Costs and Length of Stay, Hilton 
Anaheim, California C 
200 p.m.3:30 p.m. 
Novel Applications of 
ensional Echocardio- 
graphy, Hilton Anaheim, Pacific C 
2~00 p.m.-3:30 p.m. 
Myocardial Contrast 
Echocardiograph 
Observations, ? 
: Experimental 
HI ton Anaheim, 
Pacific D 
Em 
2:30 p.m.-3r30 p.m. 
How to Evaluate Rest 
Angina in the Emergency Room, 
Anaheim Convention Center, 
Room 212B NE 
2:30 p.m.-3:30 p.m. 
Contrast Echo: Getting 
Started, Anaheim Convention 
Center, Room 2095 m 
3~00 p.m.-5:OO p.m. 
Moderated Poster 
Session...Mvocardial lschemia 
and Viabilit);: Clinical Studies, 
Anaheim Convention Center, Hall A 
anon ana Management, Anandm 
4~00 p.m.-5:OO p.m. 
mmGardiac Masse?;: Eyal,u- 
Convention Center Room 2095 m 
4:OO p.m.+00 p.m. 
Em Assessment of 
Myocardial Viability With Sinqle 
diography and Doppler lmagin 
Anaheim Convention Center, 7 Hal A 
Noon-2:00 p.m. 
Stress Echo: Impact on 
Prognosis, Anaheim Convention 
Center, Hall A 
Photon Emission computed - 
Tomography, Anaheim Convention 
Center, Room 2 17 B #a 
400 p.m.-5:30 p.m. 
Nuclear Cardiolo 
Stress Perfusion Imaging an % 
y: 
Prognosis, Hilton Anaheim, Pacific D 
xvii 
8:30 a.m.lO:OO a.m. 
Late Breaking Clinical 
Trials II, Anaheim Convention 
Center, Arena 
m 8:30 a.m.-Noon 
B Controversies in 
Cardiology, Anaheim Convention 
Center, Ballroom C 
m ;;;o;ay;~;~p;)aopah’ymYZK 
and Beyond, Hilton Anaheim, 
California C 
830 a.m.-IO:00 a.m. 
Myocardial Contrast 
Echocardiography in Humans, 
Hilton Anaheim, Pacific D 
m 9:OO a.m.-IO:00 a.m. 
Lpt Current Status of 
Positron Emission Tomography, 
Anaheim Convention Center, 
Room 211A m 
IO:30 a.m.-Noon 
Featured Oral Abstract 
Session...Cardiac Magnetic 
Resonance Imaging: Left 
Ventricular Function, Myocardial 
Viability, Hi/ton Anaheim, 
California A 
IO:30 a.m.-Noon 
Diastology: Novel 
Hemodynamic Insights, 
Hilton Anaheim, California B 
lar Heart Disease: 
nfion Center, Hall A 
Measurement of 
Cardiac Structure and Function: 
New Three-Dimensional 
Echocardiography Approaches, 
Anaheim Convention Center, Hall A 
m 9:OO a.m.-l&00 a.m. 
B Echo/Doppler to 
Assess Suitabilitv of Mitral Valve 
Noon-200 p.m. 
New Techniques in 
Ultrasound: Miscellaneous II, 
Repair, Anahek Convention 
Center, Room 209A zs 
m 9:OO a.m.-IO:00 a.m. 
Restriction, Anaheim Convention 
B Difficult Dilemmas in 
Center, Room JO9B 
Diastoloqy: Constriction Versus 
m 
Anaheim Convention Center, Hall A 
m 1215 p.m.-l:45 p.m. 
B How to Evaluate 
m 12:15 p.m.-l:45 p.m. 
Diastolic Function in Y2K, 
m Conservative Versus 
Hi/ton Anaheim, Pacific A m 
9:00 a.m.-II:00 a.m. In 
Ventricular Filling and 
At rial Function: New Doppler 
Insights, An aheim Convention 
Center, Hall A 
Myocardial Infarction, Hi/ton 
Anaheim, Pacific 5 zn# 
vasive Strateaiez After 
9:00 a.m.-II:00 a.m. 
New Techniques in 
Ultrasound: Miscellaneous I, 
Anaheim Convention Center, Hall A 
9:00 a.m.-II:00 a.m. 
Computed 
Tomography: Coronary 
Calcification, Myocardial 
Perfusion, Anaheim Convention 
Center, Hall A 
m IO:30 a.m.-II:30 a.m. 
B TEE Case Studies: 
Improving Technique and Inter- 
pretation, Anaheim Convention 
Center, Room 209A SE 
w1s*l: IO:30 a.m.-Noon 
B Clinical Decision 
Making, Anaheim Convention 
Center, Room 2 1 OA 
m IO:30 a.m.-Noon 
B Recoanition and 
Optimal Treatment of.lschemic 
Left Ventricular Dysfunction, 
Hi/ton Anaheim, California C 
Bishop Lecture, Anaheim 
Convention Center, Ballroom A 
2:00 p.m.-3:30 p.m. 
Stress Radionuclide 
imaging and Detection of 
Coronary Artery Disease, 
Hilton Anaheim, California A 
2~00 p.m.*30 p.m. 
Ultrasound Detection 
of Myocardial Ischemia, 
Hilton Anaheim, California B 
m 2:30 p.m.-3:30 p.m. 
m Evaluation of 
Prosthetic Valves With Echo/ 
Doppler, Anaheim Convention 
Center, Room 2098 ml 
m 2:30 p.m.430 p.m. 
m Stress Echocardio- 
graphy, Anaheim Convention 
Center, Room 209A m 
m 2:30 p.m.&30 p.m. 
m Telemedicine and 
Clinical Practice, Anaheim Con- 
vention Center, Room 208A m 
3:00 p.m.-5:OO p.m. 
Contrast Echo- 
cardiography: Left Ventricular 
Opacification, Anaheim 
Convention Center, Hall A 
3~00 p.m.-5:OO p.m. 
Magnetic Resonance 
imaging: Imaging Atherosclerosis, 
Anaheim Convention Center, Hall A 
300 p.m.-5:OO p.m. 
Radionuclide imaging 
of Flow and Metabolism, Anaheim 
Convention Center, Hall A 
W 4:OO p.m.-5:OO p.m. . . 
B Optimizing Cated 
Single Photon Emission 
Computed Tomography, 
Anaheim Convention Center, 
Room 208B EiBz 
m ;rE;e’a;;yRF$y 
Assessment, Anaheim Convention 
Center, Ballroom C 
400 p.m.-5:OO p.m. 
Infective Endocarditis: 
A Comprehensive Approach, 
Hilton Anaheim, California C 
4:OO p.m.-500 p.m. 
Stress Echo: 
Assessment of Myocardial 
Viability, Hilton Anaheim, Pacific D 
m 5:30 p.m.-7:OO p.m. 
B Three-Dimensional 
Echocardiography, Hilton 
Anaheim, California B 
m 5:30 p.m.-7:OO p.m. 
B New Techniques in 
Nuclear Cardiology, 
Hilton Anaheim, Pacific D 
m 5:30 p.m.-7:OO p.m. 
B Myocardial Contrast 
Echocardiography, Hi/ton 
Anaheim, Pacific C 
m 6:OO p.m.-S:00 p.m. 
B 49th Annual 
Convocation, Disney/and Hotel, 
Terrazzo Room 
m Structured Sessions 
m (Black Boxes) 
Abstract Sessions 
(Crey Boxes) 
SessionType and 
Number are shown in 
the shaded box. Refer to 
the Scientific Sessions 
Key for more information about the 
type of session. Oral and Poster 
Abstract Sessions are grey shaded 
boxes; Structured Sessions are 
shown in black. 
m 830 a.m.-IO:30 a.m. .  4 
B ACC 2000 Meeting 
Highlights, Anaheim Convention 
Center, Arena 
530 a.m.-IO:00 a.m. 
Computed Tomo- 
graphy/Magnet/c Resonance 
Imaging: Myocardial Perfusion, 
Hilton Anaheim, California B 
U 900 a.m.-IO:00 a.m. . 
B How to Evaluate Valve 
Regurgitation With Echo/ 
Doppler, Anaheim Convention 
Center, Room 209A m 
Convention Center, Hall A 
9:00 a.m.-II:00 a.m. 
Doppler Tissue 
Imaging, Anaheim Convention 
Center, Hall A 
Trials Ill, Anaheim Convention 
Center, Ballroom C 
IO:30 a.m.-Noon 
New Radionuclide 
gents and Stressors, 
aheim, California A 
‘IO:30 a.m.-Noon 
New Techniques in 
Echocardiography, Hilton 
Anaheim, California B 
m 12:15 p.m.-l:45 p.m. . 
B Echocardiography in 
Stroke: When, Which Modality 
and Impact, Anaheim Marriott, 
Salon I m 
m 12:15 p.m.-l:45 p.m. 
B Optimizing Strategies 
for Risk Stratification of Coronary 
Artery Disease Patients in a 
Managed Care Environment, 
Anaheim Marriott, Salon B m 
The SessionTitle and its Location 
are listed next. 
m Some sessions require a 
Ticket and are so noted. 
Sessions listed within a shaded 
area are part of the Echo2000 
Spotlight Sunday program, and 
require the special registration 
fee. 
XVIII 
m 9:00 a.m.-Noon 
‘R;I Advances in the 
Management of Arrhythmias in 
Congenital Heart Disease, 
4naheim Convention Center, 
Room 2 1 OA m 
m Noon-2:00 p.m. 
B 17th Annual Sympo- 
sium for Directors of Pediatric 
Cardiology Programs (Luncheon), 
Won Anaheim, Pales Verdes 
Noon-2:00 p.m. 
Adult Congenital 
ieart Disease I, Anaheim 
Convention Center, Hall A 
m 2:00 p.m.-5:OO p.m. 
B The Fontan Operation: 
Current Issues in Management, 
4naheim Convention Center, 
!ecture Hall A2 am 
400 p.m.b:OO p.m. 
Pediatric Interven- 
:ional Catheterization I, Anaheim 
Convention Center, Hall A 
m 530 p.m.-7:OO p.m. 
u! Management of 
Obstructive Pulmonary Veins, 
Anaheim Convention Center, 
Room 304A 
m 9~00 a.m.-900 a.m. . . 
B Presidential Plenary 
Session, Anaheim Convention 
Center, Arena 
9~00 a.m.-11:OO a.m. 
Pediatric Interven- 
tional Catheterization II, Anaheim 
Convention Center, Hall A 
m 9:15 a.m.-l&30 a.m. . ~ 
m Late Breaking Clinical 
Trials I, Anaheim Convention 
Center, BaUroom C 
m 9:15 a.m.-l&30 a.m. . . 
u?T Common Problems in 
Pediatric Cardiology, Hi/ton 
Anaheim, California C 
m ~;;O;i~.--;l~ a.m. 
Congenital Heart Disease, 
Anaheim Convention Center, 
Room 2125 m 
m 
II:00 a.m.-12:15 p.m. 
Right Ventricular 
Failure in Congenital Heart 
Disease, Hi/ton Anaheim, Pacific C 
Noon-2:00 p.m. 
Pediatric Cardiac 
Surgery I, Anaheim Convention 
Center, Hall A 
m 12:15 p.m.-l:45 p.m. . 
B Cardiomyopathy, 
Myocarditis, and HIV, Hi/ton 
Anaheim, ‘Huntington PlEQl 
Surgery II, Hi/ton Anaheim, 
California A 
&u,d 2~30 p.m.3:30 p.m. . 
w Interventions: Adult 
Congenital Heart Disease, 
Anaheim Convention Center, 
Room 2088 m 
300 p.m.-5:OO p.m. 
Pediatric Echocardio- 
graphy, Anaheim Convention 
Center, Hall A 
m 4~00 p.m.-%00 p.m. 
m Management of 
Children After Heart Trans- 
plantation, Anaheim Convention 
Center, Room 2 12A m 
m 4:OO p.m.S:OO p.m. 
B Intensive Care Unit 
Management After Surgery for 
Single Ventricle/Hypoplastic Left 
Heart Syndrome, Anaheim Con- 
vention Center, Room 2 17A m 
4~00 p.m.-*30 p.m. 
Pediatric Echocardio- 
graphy and Magnetic Resonance 
Imaging, Hi/ton Anaheim, 
California A 
9:00 a.m.-Noon 
Surgical Options for 
Valvular Heart Disease: Indica- 
tions and Long-Term Results, 
Anaheim Convention Center, 
Room 207A En 
Noon-2:00 p.m. 
Moderated Poster 
Session...Mitral Valve Disease: 
Etiology, Diagnosis, Therapy, 
Anaheim Convention Center, Hall A 
Noon-2:00 p.m. 
Aortic Valve Disease: 
Etiology/Pathology, Anaheim 
Convention Center, Hall A 
4~00 p.m.-&00 p.m. 
Rheumatic Carditis/ 
Mitral Stenosis, Anaheim 
Convention Center, Ha// A 
5:30 p.m.-7:OO p.m. 
Assessing Severity of 
Valvular Heart Disease, Hi/ton 
Anaheim, California 6 
m 8100 a.m.-9:00 a.m. .  a 
B Presidential Plenary 
Session, Anaheim Convention 
Center, Arena 
9:00 a.m.-1l:OO a.m. 
Mitral Valve Prolapse, 
onvention Center, Ha// A 
m 9~15 a.m.-lo:30 a.m. . 
B Late Breaking Clinical 
Trials I, Anaheim Convention 
/room C 
9:15 a.m.-IO:30 a.m. 
Valve Surgery: Trends, 
Techniques, and putcomes, 
Hi/ton Anaheim, California A 
w IO:30 a.m.-11:30 a.m. . . 
m Valvular Heart Disease: 
Why to Cath in Y2K, Anaheim 
Convention Center, Room 2 11 B 
SIB 
m Il:dO a.m.-12:15 p.m. . . 
B Current Status of 
Mitral Valvuloplasty, Anaheim 
Convention Center, Lecture Hall A 7 
Noon-2:00 p.m. 
Aortic Valve Replace- 
ment: New Approaches, Anaheim 
Convention Center, Ha// A 
m 12:15 p.m.-l:45 p.m. 
& Surgical Approaches 
to Mitral Regurgitation, Hi/ton 
Anaheim, Capistrano ma 
m 12:15 p.m.-l:45 p.m. . 
m Prosthetic Valves: 
Current Dilemmas, Anaheim 
Marriott, Salon B BE 
M 2:30 p.m.&30 p.m. . 
m Management of Aortic 
Stenosis in the Elderly, Anaheim 
Convention Center, Room 27 7B 
m 
3:00 p.m.-5:OO p.m. 
Valve Disease: 
Anticoagulation/Thrombolysis, 
Anaheim Convention Center, Ha// A 
m 4~00 p.m.-5:30 p.m. ‘. 
m Management of the 
Asymptomatic Patient With 
Valvular Heart Disease, /-/i/ton 
Anaheim, California C 
xxi 
930 a.m.-l&00 a.m. 
Late Breaking Clinical 
frials II, Anaheim Convention 
Center, Arena 
m 200 p.m.-3:OO p.m. .  2 
B 31st Annual Louis F. 
Bishop Lecture, Anaheim 
Convention Center, Ballroom A 
8:30 a.m.-Noon 
Controversies in 
m 2~00 p.m.*30 p.m. 
m Mitral Reauraitation in 
Cardiology, Anaheim Convention 
Center. Bal/room C 
Patients With Coron&y%rtery 
Disease and Left Ventricular 
930 a.m.-%%00 a.m. 
Dysfunction, Hi/ton Anaheim, 
Featured Oral Abstract California C 
Session...Aortic Stenosis: Hiqh 
Gsk, Sudden Death, Valve - 
teplacement, Hi/ton Anaheim, 
California 6 
9:OO a.m.-IO:00 a.m. 
Echo/Doppler to 
lssess Suitability of Mitral Valve 
?epair, Anaheim Convention 
Center, Room 209A m 
#j#= 
IO:30 a.m.-Noon 
Clinical Decision 
vlaking, Anaheim Convention 
Center, Room 2 I OA 
m 
IO:30 a.m.-Noon 
Frontiers in Valvular 
ieart Disease, Hi/ton Anaheim, 
hxific D 
m 2~30 p.m.-3:30 p.m. . . 
B Catheter Balloon 
Valvuloplasty for Mitral Stenosis, 
Anaheim Convention Center, 
Room 21 IA sa 
M 2:30 p.m.-3:30 p.m. 
B Evaluation of Prosthetic 
Valves With Echo/Doppler, 
Anaheim Convention Center, 
Room 209B m 
3:OO p.m.-5:OO p.m. 
Aortic Valve Disease: 
Pathology, Etiology, Diagnosis, 
Anaheim Convention Center, Hall A 
m 4:OO p.m.-500 p.m. . . 
m Infective Endocarditis: 
A Comprehensive Approach, 
Hi/ton Anaheim, California C 
Aortic Stenosis and 
Valve Prosthesis-Patient 
4~00 p.m.-5:OO p.m. 
Aortic Stenosis: 
Physiology, Natural History, 
Hi/ton Anaheim, California A 
\/lismatch, Anaheim Convention 
Center, Hall A 
m 5:30 p.m.+00 p.m. 
B Anorectic Drugs and 
Valvular Heart Disease, Hi/ton 
Anaheim, California A 
m 6:OO p.m.-&00 p.m. , 
B 49th Annual 
Convocation, Disney/and Hotel, 
Terrazzo Room 
Ce 
E 
Re 
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Ro 
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Di 
Ml 
m 530 a.m.-l&30 a.m. 
m ACC 2000 Meeting 
ghlights, Anaheim Convention 
,nter, Arena 
m 9:OO a.m.-%X00 a.m. 
m How to Evaluate Valve 
gurgitation With Echo/Doppler 
raheim Convention Center, 
Nom 209A m 
9:OO a.m.-II:00 a.m. 
Infective Endocarditis: 
orbidity/Mortality, Anaheim 
Invention Center, Hall A 
m lo:30 a.m.-Noon 
m Late Breaking Clinical 
als Ill, Anaheim Convention 
mnter, Ballroom C 
m lo:30 a.m.-Noon 
m Golden Moments for 
:ervention in Valvular Heart 
sease, Hi/ton Anaheim, 
rlifornia C 
d Left Ventricular Dysfunction, 
/ton Anaheim, Laguncl w 
m 12:15 p.m.-l:45 p.m. 
m Congenital Heart 
sease in Pregnancy, Anaheim 
arriott, Salon 3 ai 
Be sure to check the Final 
Program onsite in Anaheim, 
for all location and program 
updates. ACC2000 
preregistrants may pick up 
portfolios and Final Programs 
at Registration in the Anaheim 
Convention Center, Hall C. 1 
m Structured Sessions . . 
m (Black Boxes) 
Abstract Sessions 
(Crey Boxes) 
m SessionType and . . 
m Number are shown in 
the shaded box. Refer to 
the Scientific Sessions 
Key for more information about the 
type of session. Oral and Poster 
Abstract Sessions are grey shaded 
boxes; Structured Sessions are 
shown in black. 
The Session Title and its Location 
are listed next. 
m Some sessions require a 
Ticket and are so noted. 
Sunday, March 12 
noon-5 pm 
Monday, March 13 
9 am-5 pm 
Tuesday, March 14 
9 am-5 pm 
Wednesday, March 15 
9 am-noon 
xxii 
m 5~00 a.m.-5:00 p.m. 
B Professional 
Development: Enhancing 
Effectiveness and Managing 
Change, Disneyland Hotel, Grand 
South 6 m 
.  2 -4 Noonb:OO pm. 
U Strateqies for 
Success-Produced With the 
Cooperation of Emory University 
School of Medicine, Disney/and 
Hotel, Grand North B m 
B Structured Sessions 
m (Black Boxes) 
Abstract Sessions 
(Crey Boxes) 
m Session Type and 
m Number are shown in 
the shaded box. Refer to 
the Scientific Sessions 
Key for more information about the 
type of session. Oral and Poster 
Abstract Sessions are grey shaded 
boxes; Structured Sessions are 
shown in black. 
The.SessionTitle and its Location 
are listed next. 
m Some sessions require a 
Ticket and are so noted. 
Sunday, March 12 
noon-5 pm 
Monday, March 13 
9 am-5 pm 
Tuesday, March 14 
9 am-5 pm 
Wednesday, March 15 
9 am-noon 
m 900 a.m.-Noon 
N Self-Assessment and 
Clinical Cardiology: Challenge 
Yourself With ACCSAP Questions, 
Anaheim Convention Center, 
Room 304C 
m Noon-2:00 p.m. 
m 17th Annual 
Symposium for Directors of 
Pediatric Cardiology Programs 
(Luncheon), Hilton Anaheim, 
Pales Verdes 
m . . 
B 
Noon-2:00 p.m. 
26th Annual 
Symposium for Directors of Adult 
Cardiology Programs, Hi/ton 
Anaheim, Pacific 6 
Noon-2:00 p.m. 
Towards Efficiency in 
Heart Care, Anaheim Convention 
Center, Hall A 
Integrating Physiology and 
Decision Making, Anaheim 
Convention Center, Room 2 13A 
Session...Cardiac Quantification 
Software and Validation, Anaheim 
Convention Center, Hall A 
4:OO p.m.-6:00 p.m. 
Moderated Poster 
Session...Evaluating and 
improving Outcomes in 
Congestive Heart Faifure, 
Anaheim Convention Center, Hall A 
4:00 p.m.-&00 p.m. 
Outcomes Evaluation 
in Coronary Heart Disease, 
Anaheim Convention Center, Hall A 
W 5:00 a.m.-g:00 a.m. 
d Presidential Plenary 
Session, Anaheim Convention 
Center, Arena 
m 9:00 a.m.&15 a.m. .  1 
B Business Meeting of 
the College, Anaheim Convention 
Center, Arena 
900 a.m.-11 :OO a.m. 
Outcomes After 
Coronary Revascularization, 
Anaheim Convention Center, Hall A 
900 a.m.-12:30 p.m. 
Computer Appli- 
cations: Telemedicine, Anaheim 
Convention Center, Hall D 
m 915 a.m.-IO:30 a.m. . , 
m *I5 a.m.-l&30 a.m. .  2 
B Health Svstem Reform 
2OOO...Turf, Borders, and 
Referees: Who Decides What 
Cardiologists Can Do?, Hi/ton 
Anaheim, California 6 
Case Demonstrations IV, 
Anaheim Convention Center, Arena 
m 11:00 a.m.-12:15 p.m. . . 
B Update on the ABIM, 
Hilton Anaheim, California A 
m II:00 a.m.-12:30 p.m. . . 
B Young Investigators 
Awards Competition: Physiology, 
Pharmacology, and Pathology, 
Hilton Anaheim, California B 
Noon-2:00 p.m. 
Evaluating Outcomes 
in Coronary Artery Disease, 
Anaheim Convention Center, Hall A 
m 12:15 p.m.-l:45 p.m. 
m Women in Cardiology 
Committee Special Luncheon: 
The Path to Leadership in 
Cardiology, Anaheim Marriott, 
Salon D m 
(continued next page) 
m I:30 p.m.3:30 p.m. 
B Interventional Case 
Demonstrations V, Anaheim 
Convention Center, Arena 
1:30 p.m.-%00 p.m. 
Computer Applications: 
Interactive Educational Programs, 
Anaheim Convention Center, 
Ha// D 
2:00 p.m.-%30 p.m. 
Joint Symposium: 
European Society of Cardiology/ 
American College of Cardiology 
-Acute Coronary Syndromes... 
From Mechanisms to Thera- 
peutics, Anaheim Convention 
Center, Ballroom C 
m 2~00 p.m.430 p.m. 
B Young investigators 
Awards Comoetition: Molecular 
and Cellular Cardiology, 
Hi/ton Anaheim, California 5 
2:00 p.m.-3:30 p.m. 
Cost-Effectiveness of 
Advances in Cardiac Care: 
Devices and Drugs, Anaheim 
Marriott, Marquis Northwest 
3:00 p.m.-5:OO p.m. 
Risk Factors and 
Long-Term Outcomes in Heart 
Disease, Anaheim Convention 
Center, Ha// A 
m 400 p.m.&30 p.m. . , 
B Controversies in 
Interventional Cardiology, 
Anaheim Convention Center, Arena 
=gj# 
4:OO p.m.&30 p.m. 
ACCiMerck Fellowship 
Awards 20th Anniversary 
Commemorative Session, 
Hi/ton Anaheim, Pacific C 
m 4:OO p.m.-5:30 p.m. .  2 
B Young Investigators 
Awards Competition: Clinical 
Investigations, Hilton Anaheim, 
California B 
8~30 a.m.-10:OO a.m. 
Late Breaking Clinical 
Trials II, Anaheim Convention 
Center, Arena 
m 
8:30 a.m.-Noon 
Controversies in 
Cardiology, Anaheim Convention 
Center, Ba//room C 
m 
8130 a.m.-IO:00 a.m. 
Implications of 
Genetic Screening and Therapy 
for Clinical Care in Cardiology, 
Anaheim Marriott, Marquis Center 
9:OO a.m.-II :OO a.m. 
Quality of Care in 
Patients With Coronary Artery 
Disease, Anaheim Convention 
Center, Hall A 
9:OO a.m.12:30 p.m. 
Computer 
Applications: Computerized 
Medical Records I, Anaheim 
Convention Center, Hall D 
m 
IO:30 a.m.-Noon 
Clinical Decision 
Making, Anaheim Convention 
Center, Room 2 7 OA 
IO:30 a.m.-Noon 
loint Symposium: 
American College of ‘Physicians- 
American Society of Internal 
Medicine/American College of 
Cardiology-Management of 
Comorbidities in Patients With 
Cardiac Diseases, Anaheim 
Convention Center, Ballroom A 
m 
IO:30 a.m.-Noon 
Controversies in 
Pediatric Cardiology, Hilton 
Anaheim, Pacific C 
Noon-l:45 p.m. 
The Affiliates-in- 
Training Luncheon Forum: 
Professionalism and Ethics in Your 
Training Program, Anaheim 
WestCoast, Park Ballroom 
Noon-2:00 p.m. 
Improving Outcomes 
in Coronary Disease and 
Congestive Heart Failure, 
Anaheim Convention Center, Hull A 
I:30 p.m.-500 p.m. 
Computer Applications: 
Expert Systems and Neural 
Networks, Anaheim Convention 
Center, Ha// D 
m 2:00 p.m.3:OO p.m. .  1 
B 31st Annual Louis F. 
Bishop Lecture, Anaheim 
Convention Center, Ballroom A 
m 2:00 p.m.3:30 p.m. . . 
B Pediatric Cardiology 
Clinical Decision Making, 
Hi/ton Anaheim, Pacific C 
m 2:00 p.m.-3:30 p.m. 
B Sesion Conjunta con 
la Sociedad Interamericana de 
Cardiologia/American College 
of Cardiology-Problemas 
Relevantes en Cardiologia: 2000, 
Hi/ton Anaheim, Pacific D 
M 2~30 p.m.-3:30 p.m. . 
B Telemedicine and 
Clinical Practice, Anaheim 
Convention Center, Room 208A 
3:00 p.m.S:OO p.m. 
Outcomes in Coronarv 
Treatment: PTCA and Antiplatelet 
Drugs, Anaheim Convention 
Center, Ha// A 
m 4:OO p.m.S:OO p.m. 
m Joint Symposium: 
Association of Black Cardioloaists/ 
American College of Cardiology 
-Ethnic and Gender Disparities 
in Cardiovascular Mortality...The 
Scientific Basis, Mechanisms, and 
Strategies for Closing the Gap in 
the New Millennium, Anaheim 
Convention Center, Room 2 7 OA 
w1s*r 4:OO p.m.-5:OO p.m. 
m 31 st Annual Bethesda 
Conference Report: Emergency 
Cardiac Care, Hi/ton Anaheim, 
California 5 
m 400 p.m.-5:OO p.m. . , 
m ACC National Cardio- 
vascular Data Registry and STS 
Database Programs Working to 
Improve Patient Care, Anaheim 
Convention Center, Room 273A 
m 4:OO p.m.-5:OO p.m. 
m Preoperative Risk 
Assessment, Anaheim Convention 
Center, Ballroom C 
4:OO p.m.-5:OO p.m. 
Implementing “Tools” 
to Improve Cardiovascular Care, 
Anaheim Marriott, Marquis 
Northwest 
m 5:30 p.m.&30 p.m. 
B Optimal Coding for 
the Cardiovascular Specialist, 
Anaheim Convention Center, 
Room 2 1 OA 
Convocation, Disney/and Hotel, 
Terrazzo Room 
B 8~30 a.m.-l&30 a.m. 
m ACC 2000 Meeting 
ghlights, Anaheim Convention 
enter, Arena 
d/ A 
9:OO a.m.-II ~00 a.m. 
Efficiency in Cardiac 
eim Convention Center, 
300 a.m.-Noon 
Computer 
lplications: Computerized 
edical Records II, Anaheim 
)nvention Center, Ha// D 
B IO:30 a.m.-Noon 
m Late Breaking Clinical 
ials Ill, Anaheim Convention 
enter, Ballroom C 
B IO:30 a.m.-Noon 
m Defining Quality of 
are in Cardiovascular Disease in 
e Year 2000, Anaheim 
Invention Center, Room 207A 
B 12:15 p.m.-l:45 p.m. 
m Tax and Estate 
anning for the 21 st Century, 
i/ton Anaheim, Huntington m 
B 12:15 p.m.-l:45 p.m. 
m How Should We Use 
ie ACC and STS Databases? 
;/ton Anaheim, Pales Verdes 
B 12:15 p.m.-l:45 p.m. 
m Congenital Heart 
isease in Pregnancy, Anaheim 
‘arriott, Salon 3 zm 
Be sure to check the final 
Program onsite in Anaheim, 
for all location and program 
updates. ACC2000 
preregistrants may pick up 
portfolios and Final Programs 
at Registration in the Anaheim 
Convention Center, Hall C. 
xxiv 
Daily Concurrent Education Sessions 
Sunday, March 12,200O 
Spotlight Sessions 
m CC Arena, Bollroom A, 
k Ballroom C, Hall A 7 
Mini-Courses 
w Controversial Topics in . 
m Pacing-CC Room 273C 
m Rest Angina Without ST- 
& Segment Elevation: 
m Contemporary 
Management-CC Room 273 
Eyli Targeting the 
Endothelium- 
m Marriott Marquis Northeast 
Advances in the 
Management of 
Arrhythmias in Congenital 
Heart Disease-CC Room 2 7 OA 
m Optimal Use of Noninvasive 
Techniques in the 
m Management of Heart 
Failure-CC Hall A2 
m Self-Assessment and Clinical 
kimk Cardiology: Challenge 
m Yourself With ACCSAP 
Questions-CC Room 304C 
Surgical Options for Valvular 
Heart Disease: indications 
and Long-Term Results 
-CC Room 207A 
m Ventricular Arrhythmias and 
m ii,"c~~$c~~~~i~m~~~~thy 
-CC Room 304A 
Resonance Imaging- 
Marriott Marquis Northwest 
Poster Sessions Spotlight Sessions 
Diaonosk Theraov-Hall 
ocardial Infarction: Marriott Marquis Center 
Intravascular Radiation 
Coronary Stenting: 
Clinical Outcomes 
Vascular Biology: Clinical and 
Experimental--Hall A 
isms and Treatment of 
Aortic Valve Disease: 
Etiology/Pathology 
-Hall A 
Diastolic Dysfunction and 
Heart Failure-Hall A 
Dilated Cardiomyopathy 
-Hal/ A 
--r-..- .-- .-.... 
Computed Tomography/ 
Adult Congenital Heart 
Disease I-Hall A 
Towards Efficiency in Heart 
Care-Ho// A 
xxix 
Meet the Experts 
,‘Q4 Office Management of ICDs 
h 
- -CCRoom209A 
- Statins, Niacin, or Fibrates? 
b-. 
-CC Room 208A 
m 111 Functional Assessment of the Borderline 
IFn 
B-M Lesions-CC Room 2128 
Arrhythmias in Heart Failure 
m -CCRoomZOL?B 
m Cardiac Masses: 
- Evaluation and Management- 
CCRoom209B 
* ,.‘q Management of Children After Heart 
- Transplantation-CC Room 212A 
* ,-4 KU Management After Surgery for Single 
m&m 
q Ventricle/Hypoplastic Left Heart 
Svndrome-CC Room 21 IA 
Assessment of Myocardial Viability With 
SPECT-CC Room 2 I I6 
Scientific Sessions 
m ESCIACC Symposium 
m (cont’d)-CC Ballroom C 
m Controversies in Interventional 
t?-. 
Cardiology-CC Arena 
m ACC/Merck Fellowship Awards 20th ,. 
- Anniversary Commemorative Session- 
Hi/ton Pacific C 
,. ‘7~14 Young investigators Awards Competition: 
1 
‘ , Clinical Investigations- 
- Hilton California B 
m Management of the Asymptomatic Patient 
. . With Valvular Heart 
- -Hi/ton California C 
Disease . . 
m Vascular Biology for the lnterventionalist 
.* 
-CCHa//AZ 
m Update on Ablation- 
. . 
CCRoom 2lOA 
Diabetes and the Heart: The Emerging 
Epidemic-Marriott Marquis Center 
Featured Oral Abstract Session...Effects of 
Brachytherapy for Prevention of 
Restenosis-CC Room 207A 
Atrial Fibrillation/Flutter: Noninvasive Risk 
Assessment -CC Room 304C 
Nuclear Cardiology: Stress Perfusion 
Imaging and Prognosis-Hi/ton Pacific D 
ACC Chapter Night 
See the 
Final Program 
for a complete 
schedule of 
ACC Chapter Receptions. 
Anaheim Convention Center, Hall C 
Anaheim Convention Center, Halls B-D 
Mini-Courses 
&k&h 
m The Aging Heart: Integrating Physiology 
- 
and Decision Making-CC Room 213A 
m New Management Concepts During the 
d Early Hours of Infarction-CC Room 21OA 
Important Issues Common to Cardiac 
Surgery and Cardiology-CC Room 304A 
mm 
Cardiovascular Disease Prevention 
in the Insulin-Resistant Patient 
UE-CCRoom213C 
Basic Mechanisms in Heart Failure: Why 
Does the Heart Fail? Implications for 
Treatment-Marriott Marouis Northwest 
m The Fontan Operation: Current Issues in ,. 
m Management-CC Ha// A2 
. Analysis of Complex Arrhythmias 
d -CC Room 207A 
b Nuclear Cardiology in Patients ‘A&h 
- Coronary Artery Disease: An Evidence- 
Based Approach to Diagnosis and 
Prognosis--Marriott Marquis Northeast 
Poster Sessions 
Moderated Poster Shssion... 
Cardiac Quantification Software and 
Validation-Hall A 
Moderated Poster Session...Evaluating 
and Improving Outcomes in Congestive 
Heart Failure-Hail A 
Antiplatelet and Antithrombim 
Therapies for Acute Coronary Syndromes 
-H”,, m 
Novel Approaches to the Management of 
Acute Coronary Syndromes-Hall A 
Percutaneous Interventions: 
Coronary Outcomes-Hall A 
Coronary Stenting: Basic Aspects 
IVUS Insights Into Percutaneous 
Revascularization-Hall A 
Newer Therapies in 
Cardiovascular Disease 
-Al”,, A 
Benefits of Lipid Lowering 
-Ha/l A 
Rheumatic Carditisi 
Mitral Stenosis-Hal/ A 
tosis: Relationship to Oxidative Stress 
Determinants of Exercise Tolerance 
Atrial Fibrillation: Thromboembolic 
Complications-Hall A 
iac Atrial Defibrillation 
Echo-Doppler Assessment of Myocardial 
Function and Viability-Hall A 
Tissue Doppler imaging 
Evening Sessions 
m Management of Obstructive Pulmonary ,. 
m Veins-CC Room 304A 
m!&m 
m lschemic Cardiomyopathy: When to 
- 
Revascularize-Hilton Pacific C 
m Choices in Myocardial Stress Imaging: 
- What Test? For Which Patient? 
-Hi/ton California C 
m Modern Antithrombin Therapy 
-- -CC Room 213C 
- The Noninvasive Vascular Laboratory- 
- 
Marriott Marquis Northeast 
... ,+a 507 Nonsustained VT and Sudden 
m Death-CC Room 207A 
- 
bmli& 
m Experimental Models and Novel 
Investigative Approaches to the Study and 
m Treatment of Heart Failure-CC Room 304C 
1.. Management of Atrial Fibrillation 
m -CC Rooy 2 1 OA 
m Assessing Severity of Valvular Heart 
i!m& ~~ Disease-Hi/ton California B vii 
m Alternative Revascularization Strategies: 
- PMR/DMR, Angiogenesis-CC Room 213A 
,n. 
- Achieving Optimal Risk Reduction 
- 
Outcomes in Cardiovascular Prevention- 
Marriott Marquis Northwest 
I ;, ’ 
“,, .I; ‘_, ‘4 : 
, :, i ..,,, /i.‘) ‘” / : : \z :i,: ;. .I’ 
I)& ,. ‘ ‘, ~,*.‘,‘i’” ~ ‘ 
‘, 
f _ 
.,’ -. 
,. : I’. ‘. ., / 1 
> ” ‘-,‘. 
Registration Hours: 
7:00 a.m.-7:OO p.m. 
Anaheim Convention Center, Hall C 
xxvi 
Dailv Concurrent Education Sessions 
Monbay, March 13,200O 
Special Sessions 
m Presidential Plenary Session ,. 
m (8:OO a.m.-!%00 a.m.)-- 
- CC Areno 
F Business Meeting of the 
d College (9:00 a.m.-915 a.m.) 
CT Awno 
Meet the Experts 
m Management of the 
h Patient With Non-Q-Wave 
Myocardral infarction 
-CC Room 209A 
- Hypertensive Crises- 
- CC Room 208A 
- 
m Cine Film Replacement- 
‘* CCRoom 212~7 
- 
m Stent Selection- 
- 
CC Room 208B 
ACE-Inhibitors, A-II 
Antagonists, and Beta- 
Blockers in Heart Failure: 
Which One(s)?-CC Room 212A 
,wrrg Pacing in CHF- 
‘- CC Room 21 IA 
- 
m Newer Applications in 
m Nuclear Cardiology- 
- CCRoom211B 
Diastolic Function: How to’ 
Use Tissue Doppler and 
Flow Propagation- 
CC Room 2098 
Poster Sessions 
Moderated Poster Session... 
Pacing for Atrial Fibrillation 
Prevention-Hall A 
Myocardial Infarction: 
Determinants of Remodeling 
-Ho,, A 
High Risk Subsets 
-Ha// A 
Coronary Brachytherapy I 
-Ha// A 
Endovascular Treatment of 
Abdominal Aortic Aneurysm- 
Ho/f A 
Restenosis: Basic Research II 
Metabolic Abnormalities and 
Mrtra Va ye Pro apse 
Failure-Ho// A 
Exercise Training Effects 
-Ha// A 
Catheter Ablation/Atria1 
Fibrillation/Atrial Flutter 
-Ho/f A 
Pacing and Arrhythmia 
Mechanisms-Ha// A 
T-Wave Altemans 
-Ha// A 
Myocardial Contrast 
Echocardiography 
-Hall A 
Cardiac Magnetic Resonance 
Imaging: Left Ventricular Size 
and Function-Hall A 
Radionuclide Assessment of 
Myocardial Viability-Hall A 
Pediatric Interventional 
Catheterization II 
-Hal/ A 
Outcomes After Coronary 
Revascularization-Ha/l A 
Scientific Sessions 
*’ Late Breaking Clinical Trials I 
z -CC BaNroom C 
m Health System Reform 
& 2000--Hi/ton California B 
- Why Don’t We Do It Better? 
. . 
- 
Prevention in Cardiology 
Practice--Marriott Marquis 
Cellt.% 
m ACCIAHA PTCA 
& Guidelines-CC Ho/l A7 
l ,*- 8-1 lntracoronary Radiation: 
. . 
m Part l-CC Hall A2 
m Is It Possible to Prevent . 
6 Heart Failure? Reviewing the 
Evrdence-CC Ballroom A 
m Common Problems in . . 
h Pediatric Cardiology- 
Hdton California C 
Featured Oral Abstract 
Session...Innovative Tech- 
Exercise Tolerance in Heart 
Failure-CC Room 304A 
Atrial Defibrillation 
-CC Room 304C 
Stress Echo: Advances in 
Quantitation--Hi/ton 
xxvii 
Poster Sessions Scientific Sessions Luncheon Panels Meet the Experts 
m How and When to Treat 
q Silent Ischemia- 
- a. CC Room 209A 
Moderated Poster Session... 
Infection, Inflammation, and 
cute Coronary Syndromes: 
“ce of Serum Markers 
- Intermittent Claudication: 
q Therapeutic Options- 
m CC Room 208A 
m Rotational Atherectomy- 
miim 
CC Room 21 IA 
m Live Interventional Case 
m Demonstrations IV 2, 
1 (lo:00 a.m.-Noon)- 
CC Arena 
Young Investigators Awards 
Patholoav-Hi/ton Colifomia B 
Function-Hilton Palm 
,. m Difficult Hemodynamic 
p Dilemmas: Interpretation 
and Management- 
CC Room 272A 
y Women in Cardiology 
& CommIttee Special Luncheon: 
The Path to Leadership in 
Cardiology--Marriott Salon D 
Surgical Approaches to 
Mitral Regurgitation 
-Hi/ton Capistrano 
. E ~;;+M;.;y;;;$hlete~ 
Optimal Evaluation and 
Management of the 
Asymptomatic Patient at 
High Risk for CAD-Hi/ton Pacific t3 
Evaluation of Chest Pain in 
the Emergency Room- 
Marriott Salon 7 
w Prosthetic Valves: Current 
d Dilemmas--Marriott Salon 5 
m Medical Treatment of 
kk 
Neurocardiogenic 
Syncope-CC Room 2088 
Valvular Heart Disease: 
m CCRoom2116 
Why to Cath in YZI<- 
m MRI in Cardiology- 
wiim 
‘- CC Room 209B 
m Prevention of Sudden 
. . 
w Cardiac Death- 
- 
.,. 
CC 6o/lroom C 
Coronary Stenting I 
-Ho// A 
m Emerging Issues in 
. . 
- CC Ballroom A 
.I Transplantation- 
m Current Status of Mitral 
m . . Valvuloplasty-CC Hall Al 
Restenosis: Basic and Clinical 
~ Cyanotic Adult 
~ Conqenital Heart Disease- 
m CC Rbom 2128 
Endothelial Dysfunction 
-Hall A 
ion and Related 
nts of Atheroscleroric 
inical Studies-Hall A 
bm- 101 CP Ilb-llla Inhibitors and 
mk 
Low Molecular Weight 
Heparin: When Should They 
Be Used?-Marriott Salon F 
and Experimental II 
Long-Term Outcomes of 
Percutaneous Coronary 
Intervention-CC Room 207A 
etics and the Role of 
Growth Factors- 
New Methods to Assess 
Myocardial Function 
-!-I”,, A 
CC Room 2 7 3A 
Atrial Fibrillation: Therapy 
CC Room 304A 
Pacing for Congestive Heart 
Failure-CC Room 304C 
QT Dispersion 
-Hall A Transesophageal 
Echocardiography: 
Assessment of Left Atrial 
New Applications of Three- 
Dimensional Echocardiography 
and Doooler Imaaina--Ha/l A 
Structure and Function-Hi/ton Pacific D 
Molecular Cardiology: 
Vascular Injury and 
Cardioorotection- Registration Hours: 
7:00 a.m.-S:00 p.m. 
Anaheim Convention Center, 
Hall C 
Exhibit Hall Hours: 
9:00 a.m.-5:OO p.m. 
Anaheim Convention Center, 
Halls B-D 
Marriott Marquis Nbrtheast 
Neurohormones and 
Advances in Hypertension 
and Heart Failure- 
Marriott Marquis Northwest 
New Doppler Techniques 
-Ha// A 
Pediatric Cardiac Surgery I 
-Hal/ A 
Evaluating Outcomes in 
Coronary Artery Disease 
-Hall A 
. . . 
XXVIII 
Dailv Concurrent Education Sessions 
Monbay, March I$2000 
Scientific Sessions 
m Joint Symposium: ESC/ACC-Acute 
Im 
1 I Coronary Syndromes...From Mechanisms to 
Therapeutics-CC Bollroom C 
m Young Investigators Awards Competition: 
- 
Molecular and Cellular Cardiology- 
Hilton California 6 
- Emerging Risk Factors for Atherbsclerosis 
. . 
L*” 
and Their Treatment-Marriott 
Marquis Center 
m Coronary Intervention Problem Solving- 
. . CC Hall A 1 
m Nuclear Cardiologic Techniques: Reducing 
.a 
- 
. a 
Hospital Costs and Length of Stay 
-Hilton California C 
‘. +q Congestive Heart Failure Secondary to 
. . 
_ 
q 
Pure Diastolic Dysfunction 
--CC Ballroom A 
Featured Oral Abstract Session...Catheter- 
Based Ablation of Atrial Fibrillation 
-CC Room 2 1 OA 
Acute Coronary Syndromes 
New Devices for Coronary Intervention- 
CC Room 207A 
Dilated and Hypertrophic 
Cardiomyopathies: Clinical Aspects 
-CC Room 213A 
Infection, Infarction, and Plaque Stability 
-CC Room 213C 
Myocardial and Vascular Dysfunction in 
Elderly Patients-CC Room 304A 
Autonomic Nervous System-CC Room 
304c 
Novel Applications of Three-Dimensional 
Echocardiography-Hilton PO&C C 
Myocardial Contrast Echocardiography: 
Experimental Observations 
-Hi/ton Pacific D 
Pediatric Cardiac Surgery II-Hilton 
California A 
Cardiovascular Gene Therapy 
--Marriott Marquis Northeast 
Cost-Effectiveness of Advances in 
Meet the Experts 
m How to Evaluate Rest Angina 
mik 
- in the Emergency Room 
--CT Room 777R 
- Rational Therapy for Hypertension 
- 
c 
-CC Room ZO9A 
m Bifurcation Lesions- 
1 
b 
CC Room 208A 
m Interventions: Adult Congenital Heart 
L- 
* Disease-CC Room 208B 
-*q Myocarditis-Pericarditis 
km 
- -CC Room 212A 
“....,**:14 Optimal Coding and Cost-Containment in 
hi ,’ * the EP Lab-CC Room 21 IA 
Poster Sessions 
Moderated Poster Session...Myocardial 
and Viability: Clinical Studies 
Myocardial Infarction: 
Ischemia, Reperfusion, and Myocardial 
Preservation-Ho// A 
IVUS Insights Into Coronary Stenting 
Restenosis: Basic Research Ill 
Epidemiology and Outcomes of 
and Peripheral Arterial 
ponse to Treatment 
Valve Disease: 
ulation/Thrombolysis 
Diagnosis and Prognosis in Heart Failure III 
Risk Factors and Miscellaneous Problems in 
the Elderly-Ho//A 
Supraventricular Tachycardia 
--Ha// A 
Dual Chamber Defibrillators 
-Ha// A 
Magnetic Resonance Imaging: 
Valvular, Ischemic, and Hypertensive Heart 
Disease-Hall A 
Risk Factors and Long-Term Outcomes in 
Heart Disease-Ha/l A 
xxx 
Daily Concurrent Education Sessions 
Tuesday, March 14,200O 
Scientific Sessions 
m . . Late Breaking Clinical Trials II 
,*a Controversies in Cardiology- 
cc Ballroom c 
m Echocardiography Y2K and 
m .I Beyond-Hilton California C 
m Implications of Genetic *. . . Screening and Therapy for 
- Clinical Care in Cardiology- 
Marriott Marquis Center 
mmam stems & stem Grafts: 
.* 
b 
Technique, Results, 
Complications-CC Hall A2 
m Management of the 
. . 
- 
Patient With Chest Pain 
-Hilton Pacific C 
‘. --a Cardiac Manifestations of 
m . . 
- 
. 1 Systemic Diseases 
-CC Room 2 J OA 
Featured Oral Abstract 
Session...Adult Congenital 
Heart Disease II-Hilton 
California A 
Session...Aortic Stenosis: High 
Risk, Sudden Death, Valve 
Reolacement-Hi/bon California B 
Novel Catheter Based Imaging 
Methods to Assess Plaque 
Stability II 
-CC Room 207A 
insights From Heart Failure 
Clinical Trials I 
-CC Room 2J3A 
CCRoom213C 
Which Neurohumoral 
Mediators Really Control the 
Extracellular Matrix and 
Diastolic Function?-CC Room 304A 
Atrial Fibrillation: 
Prognosis in Hypertension: 
Lessons From the Major 
Studies-Marriott Momuis 
Meet the Experts 
m Managing Power Failure 
L Complicating Infarction- 
CC Room 208A 
m Approach to the Lesions 
‘- With Evidence of Thrombosis 
- -CC Room 2 J2B 
- Hyperlipidemia in the 
Young: What Is It and What 
m Do You Do About It?- 
CC Room 208B 
m New Antiarrhythmic . 
h Drugs-CC Room 2 12A 
m Current Status of PET- 
w&m 
q CC Room 2 J IA 
* ,,M Use of Pacemakers and 
h Automatic Defibrillators in 
Pediatric Patients- 
CCRoom 2116 
m Echo/Doppler to Assess 
c. ‘- Suitability of Mitral Valve 
Repair-CC Room 209A 
m 240 Difficult Dilemmas in . 
* 
- 
Diastology: Constriction vs. 
Restriction-CC Room 2095 
Poster Sessions 
Moderated Poster Session... 
Ischemia, Reperfusion, and 
Myocardial Preservation 
on/Modification 
Restenosis: Basic 
IVIJS insights Into Arterial 
Remodeling-Ha// A 
Vascular Biology: Basic I 
f the Aorta and 
ries in Diseased 
Miscellaneous Topics: Lipids 
and Cardiovascular Risk 
Atrioventricular Nodal 
Physiology and SVT 
Implantable Cardioverter- 
Ventricular Filling and Atrial 
New Techniques in 
Ultrasound: Miscellaneous I 
Computed Tomo&phy: 
Coronary Calcification, 
Mvocardial Perfusion-Hall A 
Pediatric Acquired Heart 
Disease: Kawasaki, Cardio- 
myopathy, and Connective 
Tissue Disorders-Ho// A 
Quality of Care in Patients 
With Coronary Artery 
Disease-Ha// A 
Meet the Experts 
m How to Administer CP Ilb- 
q llla Receptor Antagonists- 
- CC Room 208A 
m Interventional Approaches 
m to Claudication- 
CC Room 2088 
m Preventive Treatment After 111 ., 
q Intervention-CC Room 212A 
--q Heart Failure in the Elderly- 
‘* CC Room 21 IA 
“.....q Advanced Mapping Tech- 
L _ niques in Electrophysiology 
-CC Room 2098 
m TEE Case Studies: Improving 
d Technique and Interpreta- 1. 
tion-CC Room 209A 
’ ,,a4 How to Perform and Inter- 
4 pret TEE in Congenital Heart 
Disease-CC Room 2 128 
C Bedsi,de Monitoring of - 
m 
Plateret wnctlon- 
- CCRoom211B 
xxxi 
Daily Concurrent Education Sessions 
Tuesday, March 14,200O 
Scientific Sessions 
;F;g;zesse:in Cardiology (cont’d)- 
m Clinical Decision Making 
m -CC Room 21 OA 
B Joint Symposium: American College of ,. 
m Physicians/American Society of Internal 
m Medicine-American College of 
:ardiology-Management of Comorbidities in Patients 
Vith Cardiac Diseases-CC Ballroom A 
m Controversies in Pediatric Cardiology ,. 
@g= -Hikon Pacific c 
- Sexual Activity and the Cardiovascular 
p System-Marriott Marquis Center 
m Frontiers in Valvular Heart Disease 
m -Hi/ton Pacific D 
m Controversial issues in Coronary Stenting 141 
m -CC Arena 
m Recognition and Optimal Treatment of 
. . - lschemic Left Ventricular Dysfunction 
m -Hi/ton Cdifomia C 
atured Oral Abstract Session...Cardiac 
etic Resonance Imaging: Left 
cular Function, Myocardial Viability- 
New Insights Into Pathophysiolcgy 
of lschemic Syndromes 
-CC Room 207A 
Insights From Heart Failure Clinical Trials II 
-CC Room 2 I3A 
-CC Room 304C 
Diastology: Novel Hemodynamic Insights 
-Hi/ton California 6 
Poster Sessions 
B Moderated Poster Session... 
m Coronary Stenting: Challenging Subsets .* 
- -Ho// A 
m Myocardial Infarction: 
.1 Plasma Markers and Prognostic Studies 
- -Ho/l A 
C-Reactive Protein and Acute lschemia 
-Ho// A 
v Epidemiology and Pathophysiology of Acute 
. . m Coronary Syndromes-Hall A 
Altering the Outcome Following Acute 
lschemic Syndromes-Ho/l A 
Antiplatetet Therapy With Coronary 
l?ir41 Vascular Biology and Pharmacology: 
& Clinical-Ho/f A 
I Gene Transfer, Angiogenesis, and Myocardial 
iiE& 
li Function-Hall A 
- Antiplatelet Pharmacotherapy and 
.a Anticoagulant Monitoring 
- -Ho/l A 
Aortic Stenosis and Valve Prosthesis 
-Patient Mismatch-Ho/l A 
Atrial Fibrillation Atria F utter: 
Pathophysiology-Half A 
5ZEElES Cardiac Pacing . . . 
kiIh -Haff A 
m Ventricular Repolarization 
-Ho/l A 
Valvular Heart Disease: 
a Ne;;;modynamic Insights 
m Measurement of Cardiac Structure and 
h 
Function: New Three-Dimensional 
Echocardiography Approaches-Hall A 
v New Techniques in Ultrasound: 
a Miscellaneous II-Hall A 
v Pediatric Arrhythmias *, 
litn;r -Half A 
,. Improving Outcomes in Coronary Disease 
z an;;o;gestive Heart Failure 
Luncheon Panels 
w Diagnosis, Treatment, and Long-Term ,. 
m Fol!ow-Up of Coronary Abnormalities in 
Children-Marriott Salon 3 
I .  - Heart Failure: Beta-Blockers and beyond- 
mk 
Marriott Salon F 
- Hormone Therapy and CAD: 
m Controversies and Current Practices- 
m Hi/ton Huntington 
. . . Update on Pacing 
m -Hi/ton Laguna 
m Genetic Features of Cardiac Arrhythmias 
-Hi/ton Pales Verdes 
-a,- Managing a Patient After Heart 
d 
Transplantation: A General Cardiologist’s 
Primer-Marriott Salon D 
How to Evaluate Diastolic Function in Y2K 
z -Hilton Pacific A 
Conservative Versus Invasive Strategies 
p AJt;;zr;y;;;;;; Infarction 
m Optimal Atherectomy: Current Indications 
mzh 
and Uses-Marriott Solon 5 
Aortic Aneurysms: Diagnostic and 
m Inoperable Coronary Artery Disease- 
d 
Marriott Solon E 
m The Affiliates-in-Training Luncheon Forum, 
d Anaheim WestCoast, Park Bollroom 
Registration Hours: 
xxxii 
Dailv Concurrent Education Sessions 
Tuesbay, March 14,200O 
Meet the Emerts 
CC Room 208B 
Poster Sessions 
I It Be Used Clinicallv- Moderated Poster Session... 
Statin Therapy: More Good News 
Scientific Sessions 
Pediatric Cardiology Clinical Decision 
Making--Hi/ton Pacific C 
Treatment of Saphenous Vein Graft 
Disease-CC Room 212A 
My Worst Nightmares as an 
Myocardial Infarction: 
Miscellaneous Topics 
Novel Techniques to Assess Patients With an . . . A,.,*, r,,,,,;.. C..“Ar~mP--Un,, n 
_-..._._. -_..__.. ._.._. _ 
Stenosis-CC Room 27 7Ar’-.- 
-I in 
--t 
With Heart 
Marriott Marquis Center 
Syncope: Evaluation and Management 
Pediatric Patients-CC Room 27 76 Ancillary Therapy in the Patient 
Failure-CC Ballroom C I- a*~ Coronary Stentinq II 
Evaluation of Prosthetic Valves With 
Echo/Doppler-CC Room 2095 
Myocardial Infarction-CC Room 207A 
Percutaneous Interventvans: 
Local Deliver)-Ho// A 
m Stress Echocardiography 
& -CC Room 2OYA 
Vascular Biology/Coagulation: Basic II 
v Telemedicine and Clinical Practice- I 
Mechanisms and Epidemioloqy of Stroke 
ry Disease and Left . . 
- Ventricular Dysfunction-Hilton Cdifornia C 
Risk Factors for Adverse Outcomes of 
Percutaneous Coronary Intervention 
-f I- Hnlf A 7 
Approaches t&hromboembo& 
Hypertension: Pathophysiologic Correlates 
m Aortic Valve Disease: Pathology, Etiology, 
Diagnosis-Ho// A . . 
a Heart Failure Pathophysiology 
-Ha// A m CC Room 2 7 3A 
Myocarditis, Pericarditis, and Myxoma m Role of Clycoprotein Ilb/llla Inhibition in 
Acute Coronary Syndromes 
.., 
m 
-CC Room 273C 
- . . --Hall A 
Cardiac Transplant: 
Basic Mechanisms - , -  Cardiac Transplant Reiection and 
Basic Electrophysiology 
h -Hall A 
Immunosupp;ession 
-CC Room 304A - 
“. ~.,$.4 Atrial Fibrillation: Basic Electrophysiology- 
CC Room 304C 
Mechanisms for Sudden Death 
Stress Radionuclide Imaging and Detection 
of Coronary Artery Disease 
--Hi/ton California A 
Ultrasound Detection of Myocardial 
Ischemia-Hilton California B 
. . -Ha// A 
Atrial Fibrillation 
- 
..)_ 
-Ha// A 
Contrast Echocardiography: 
Left Ventricular Opacification 
Vascular Bioloqy 
Infection, Inflammation, and Coronary 
Maonetic Resonance Imaaina: lmaaina 
Ath;erosclerosis-Ho// A - - 
Metabolism-Ho/ 
Artery Disease 
-Marriot Marquis Northwest 
Fetal and Neonatal Cardioloqy 
m Outcomes in Coronarv Treatment: *. 
ihi -Ha,,A 
PTCA and Antiplatele~Druqs 
Dailv Concurrent Education Sessions 
Tueshay, March 14,200O 
Meet the Experts 
w lmmunosuppression . 
m Strategies in Heart Trans- 
m olantation-CC Room 2 J2A 
m Ventricular Arrhythmias: . 
h Who to Treat?- 
CCRoom2JJA 
m Optimizing Gated SPECT- 
=+if$j= CC Room 2086 
m Use of Stents in Pediatric .,. 
a Cardiology-CC Room 208A 
v How to Administer 
m Thrombolytic Therapy 
m Properly-CC Room 2 J J 6 
w . 
m 
Surgical interventions in 
CHF: Revascularization, 
Valve Repair, and 
Remodeling-CC Room 2J2B 
v Stenting Through Stents: 
I,. ‘w Managing Side Branch 
Comolications- 
CC Room 2OPB 
Scientific Sessions 
v Joint Symposium: 
ABC/ACC-Ethnic and 
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session conclud& and may be purchased at the Audio 
Tape Sales desk in the Arena Lobby. An order form will 
be available in the Final Program and via the ACC 
homepage, http://www.acc.org, in April. 
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In clinical trials, the most common 
side effects versus placebo were 
edema (8.3% vs 2.4%), headache 
(7.3% vs 7.8%), fatigue (4.5% vs 
2.8%), and dizziness (3.2% vs 3.4%). 
For more information, please visit our 
Web site at www.norvasc.com 
Please see brief summary of prescribing 
information on next page. 
